[go: up one dir, main page]

WO2004071480A1 - Use of an extract from mycorrhiza fungi - Google Patents

Use of an extract from mycorrhiza fungi Download PDF

Info

Publication number
WO2004071480A1
WO2004071480A1 PCT/EP2004/000940 EP2004000940W WO2004071480A1 WO 2004071480 A1 WO2004071480 A1 WO 2004071480A1 EP 2004000940 W EP2004000940 W EP 2004000940W WO 2004071480 A1 WO2004071480 A1 WO 2004071480A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
mushrooms
extract
skin
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/000940
Other languages
German (de)
French (fr)
Inventor
Christine Jeanmaire
Florence Henry
Gilles Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis France SAS filed Critical Cognis France SAS
Publication of WO2004071480A1 publication Critical patent/WO2004071480A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention relates to the field of cosmetics. Your goal is to use an extract of mycorrhizal mushrooms.
  • the invention further relates to cosmetic preparations which contain such an extract.
  • Mushrooms are generally known as valuable suppliers of active ingredients for the cosmetic and pharmaceutical industries. Saprophytes or pathogenic plant parasites such as, for example, Grifola frondosa or Lentinus edodes are often used in cosmetics, since they are simply cultivated z ⁇ and can be obtained to a sufficient extent with minimal resources.
  • Saprophytes or pathogenic plant parasites such as, for example, Grifola frondosa or Lentinus edodes are often used in cosmetics, since they are simply cultivated z ⁇ and can be obtained to a sufficient extent with minimal resources.
  • Mycorrhiza fungi enter into a mutually beneficial symbiosis with host plants. They belong to the Basidiomycotina or Ascomycotina (truffle).
  • the fungi receive carbohydrates from their host plants and, in exchange, regulate the absorption of the hosts by water and nutrients such as phosphates and amino acids. This symbiosis is necessary for the life cycle of the mushrooms.
  • Japanese document JP 09227333 discloses cosmetic compositions with extracts from Basidiomycetes of the Boletaceae family, which have a skin-beautifying and moisturizing effect.
  • compositions of a later product should also have optimal dermatological compatibility, so that even sensitive consumers do not react with irritation.
  • the agents should also perform other functions which simultaneously affect the technical properties of the cosmetic product, such as storage stability, light stability and formulability positively influence or at least not deteriorate.
  • the complex task of the present patent application was to find new effects of already known fungi or related species and to enable the use of these extracts in cosmetic products which are also well tolerated for sensitive skin and also have good physico-chemical properties Have stability.
  • the present invention relates to the use of an extract from mycorrhiza fungi for the production of cosmetic preparations for topical use on the skin, scalp, the epithelial appendages and / or the mucous membranes.
  • the mycorrhiza fungi are ectomycorrhiza fungi.
  • the fungus Laccaria laccata is particularly preferred.
  • the use of an aqueous extract from Laccaria laccata is a preferred embodiment of the present invention.
  • the extracts of mycorrhizal fungi when used locally on the skin, the scalp, the epithelial appendages and / or the mucous membranes produce particular biological effects and have a very good tolerance.
  • the use of at least one fraction extracted from mycorrhizal fungi as an active ingredient, alone or in conjunction with at least one other active ingredient, in a composition or a cosmetic product when used locally on the skin, scalp, epithelial appendages and / or the mucous membranes shows regenerative effects , Anti-irritant effects, anti-aging effects, UV protection, anti-protease activity, anti-alpha-5-reductase activity, protective effect against oxidative stress and anti-inflammatory activities, as well as lipolytic activity on human fat cells.
  • the extracts of mycorrhizal mushrooms are particularly suitable for the preventive and healing treatment of sensitive skin types and as a sunscreen.
  • Mycorrhizal mushroom extracts work on the scalp against alopecia. They are well tolerated.
  • the invention therefore relates to the use of extracts of the mycorrhizal fungi in cosmetic and / or dermatological preparations for sensitive skin.
  • Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic and / or dermatological agents with UV protection.
  • Sunscreens or UV light protection factors in the sense of the invention are light protection agents which are useful for protecting human skin against the damaging effects of direct and indirect radiation from the sun.
  • the sun's ulfraviolet radiation, which is responsible for tanning the skin, is divided into UV-C (wavelengths 200-280 ⁇ m), UV-B (280-315 nm) and UV-A (315-400 nm).
  • UV-B The pigmentation of normal skin under the influence of solar radiation, i.e. the formation of melanins is caused differently by UV-B and UV-A. Irradiation with UV-A rays ("long-wave UV”) results in the darkening of the melanin bodies already present in the epidermis, without any harmful effects being recognizable. This is different with the so-called “short-wave UV” (UV-B). This causes the development of so-called late pigment through the formation of new melanin grains. However, before the (protective) pigment is formed, the skin is exposed to the unfiltered radiation, which - depending on the duration of exposure - can lead to the formation of reddened skin (erythema), skin inflammation (sunburn) and even burn blisters.
  • the extracts of mycorrhiza fungi according to the invention are additionally used in combination with other sunscreens or UV light protection factors as UV absorbers or light filters (light protection factors), which convert the UV radiation into harmless heat, in order to achieve a synergistic effect.
  • sunscreens or UV light protection factors as UV absorbers or light filters (light protection factors), which convert the UV radiation into harmless heat, in order to achieve a synergistic effect.
  • UV light protection factors used in addition to the mushroom extracts are, for example, liquid or crystalline organic substances (light protection filters) at room temperature which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again.
  • UVB filters can be oil-soluble or water-soluble.
  • oil-soluble substances e.g. to call:
  • 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives e.g. 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1; 4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid-2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isocyanate ester 2-cyano-3,3- 2-ethylhexyl phenylcinnamate (octocrylene);
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives such as 2,4,6-trianilino- (p-carbo-2'-ethyl-hexyloxy) -l, 3 5 5-triazine and octyl triazone, as described in EP 0818450 AI or dioctyl butamido triazone ( Uvasorb® HEB);
  • Sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts
  • Sulfonic acid derivatives of 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bornylidene) sulfonic acid and their salts.
  • UVA filters methoxydibenzoylmethane (Parsol 1789), l-phenyl-3- (4'-isopropylphenyl) propane-l, 3-dione and enamine compounds, as described for example in DE 19712033 AI (BASF).
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm.
  • the pigments can also be surface-treated, ie hydrophilized or hydrophobized available. Typical examples are coated titanium dioxides, such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or dimethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.
  • Another object of the invention is the use of extracts from mycorrhizal fungi in agents for the preventive or curative treatment of signs of aging of the skin, scalp, the epithelial appendages and / or the mucous membranes.
  • Another name for this type of care product is anti-aging. These signs of aging include any type of wrinkles and wrinkles. Treatments include slowing skin aging. The signs of aging can have a variety of causes. In particular, these signs of aging are caused by damage to the skin induced by UV radiation. In a special embodiment of the invention, these care products are used to treat signs of aging in the skin induced by UV radiation.
  • Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic products with anti-protease activity, in particular with anti-collagenase and / or anti-elastase activity.
  • These proteases (collagenase and the different elastases) catalyze the fragmentation and destruction of the dermal macromolecules such as proteoglycan, collagen and elastin and thus lead to aging of the skin and to the effects of natural skin aging after UV radiation.
  • Another object of the invention is the use of extracts of the mycorrhiza fungi as a cosmetic anti-inflammatory agent.
  • anti-inflammatory agents are to be understood as the type of care products which can cure inflammation of the skin or which can prevent inflammation.
  • the inflammation can have a variety of causes.
  • inflammation can be treated which is caused by UV radiation, skin impurities or bacterial or hormonal skin changes, e.g. B. Acne can be induced.
  • Another object of the invention is the use of extracts from mycorrhiza fungi in protective and restorative care products for stimulating the metabolism of the skin cells with revitalizing, regenerating, moisturizing and / or reactivating Activities for the skin, scalp, epithelial appendages and / or mucous membranes.
  • Another object of the invention is the use of extracts from mycorrhiza fungi in cell-protecting agents to strengthen the immune defense of the skin.
  • This type of use of these care products has a positive effect, for example, against the negative influence of environmental pollution on the skin and / or hair, against environmental toxins or oxidative stress, by reactivating the natural functions of the skin and / or hair and making the skin and / or hair more resistant and thus strengthen the immune system.
  • Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic products to stimulate the synthesis of dermal macromolecules selected from the group consisting of collagen, elastin, fibronectin, proteoglycans, hyaluronic acid and their salts.
  • dermal macromolecules are understood in principle to be all macromolecules which are found as components of the skin either in the basement membrane between Dennis and the epidermis or in the Dennis and epidermis.
  • they are compounds selected from the group consisting of collagen, elastin, proteoglycans, fibronectins and hyaluronic acid and their salts.
  • Collagen consists of protein fibers and occurs in human skin in three different types (Type I, ITf and IV).
  • the individual polypeptide chains each with a large amount of the amino acid proline and as every third residue glycine, are wound around each other to form a triple helix.
  • the collagen fibers are synthesized as tropocol saws in the fibroblasts and discharged into the extracellular matrix.
  • the stimulation of the synthesis of collagen according to the invention leads to an increase in the production of collagen and thus to an increased intermolecular solidification of the Dennis and thus to a skin which appears firmer.
  • the elastin is also a fibrous protein. These are unstructured covalently cross-linked polypeptide chains that form a rubber-like elastic material. After synthesis, the elastin is released into the extracellular matrix in the skin cells.
  • the stimulation according to the invention of the synthesis of the elastin polypeptide chains leads to an increase in the production of elastin and thus to an increase in the elasticity of the skin.
  • proteoglycans consist of carbohydrates and proteins, but the proportion of polysaccharides predominates in proteoglycans.
  • the skin's proteoglycans contain dermatan sulfate.
  • Approx. 140 such proteoglycans with the help of smaller proteins (link proteins) accumulate non-covalently on a hyaluronic acid chain to form molecular aggregates with an average molecular weight of approx. 2 million.
  • the polyanionic aggregates which are characterized by their water-binding capacity, can form solid gels that give the supporting tissue (extracellular matrix) elasticity and tensile strength. They protect the epithelia in mucus.
  • the stimulation of the synthesis of proteoglycans and hyaluronic acid according to the invention leads to a larger amount of extracellular matrix and thus to an increased elasticity and tensile strength.
  • Fibronectin is a group of high-molecular glycoproteins (MR of the dimer approx. 440000-550000) that are found in the extracellular matrix and in extracellular fluids.
  • the fibronectin dimer connected by two disulfide bridges, an elongated molecule with the dimensions 600x25 ⁇ , binds by linear combination of three different repeating domains and the like.
  • a Collagens, glycosaminoglycans, proteoglycans, fibrin (above), deoxyribonucleic acids, immunoglobulins, plasminogen, plasminogen activator, thrombospondin, cells and microorganisms. Through these properties, it conveys z.
  • Hyaluronic acid is an acidic glycosaminoglycan
  • the basic building block of hyaluronic acid is an aminodisaccharide composed of D-glucuronic acid and N-acetyl-D-glucosamine in a (beta l-3) glycosidic bond, which is glycosidic with the next unit (beta l-4) connected is.
  • the extracts according to the invention can furthermore be used in cosmetic compositions for reducing the proteolysis and glycation of macromolecules in the skin.
  • Proteolysis is a process in which proteins are cleaved by hydrolysis of the peptide bonds using acids or enzymes. Another name for proteilysis is proteinase digestion.
  • the reduction in proteolysis according to the invention leads to a reduced cleavage of the dermal macromolecules which have a protein structure and thus to prevent the reduction in skin firming and to prevent the degradation of increased elasticity.
  • Glycation is a non-enzymatic reaction of glucose or other sugars with proteins to form glycoproteins. This reaction leads to unintentional changes to the collagen and elastin and thus to changes in the extracellular matrix.
  • Another object of the invention is the use of extracts of Myconhiza mushrooms in cosmetic products to improve wound healing.
  • Improvements in wound healing in the sense of the invention are to be understood as improvements which can support, stimulate and intensify the natural healing process in the event of a pathological change in the skin.
  • a pathological change in the skin can have various causes, one possible cause is an injury.
  • Another object of the invention is the use of extracts of Myconhiza mushrooms in cosmetic products with anti-alpha-5-reductase activity, preferably an anti-acne activity and / or an anti-Sebonhea activity for skin and / or hair.
  • the extracts according to the invention can also be used in cosmetic agents against alopecia.
  • the regenerating properties of the extract according to the invention also stimulate the scalp and thereby lead to a positive effect against alopecia, a pathologically caused hair loss.
  • the extracts according to the invention can furthermore be used in cosmetic compositions as tyrosine inhibitors and / or as skin whitening agents.
  • the skin whitening agents also known as skin whiteners, lead to a lighter skin appearance.
  • One possibility for skin lightening or whitening is through the inhibition of tyrosinase, because tyrosinase is involved in the formation of the skin pigment melanin (depigmentation).
  • the use of extracts from Myconhiza mushrooms according to the invention leads to a reduced formation of melanin and thus to skin whitening due to the inhibition of tyrosinase.
  • the extracts from Myconhiza mushrooms can additionally be used in combination with other tyrosinase inhibitors as depigmenting agents such as arbutin, fefulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C).
  • tyrosinase inhibitors as depigmenting agents such as arbutin, fefulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C).
  • the extracts to be used according to the invention are produced by customary extraction methods.
  • suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux , which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, is exemplary of Hager's Handbook of Pharmaceutical Practice, (5th Edition, Vol. 2, pp. 1026-1030, Springer Verlag, Berlin- Heidelberg-New-York 1991).
  • Fresh or dried mushrooms or mushroom components can be used as the starting material, the use of dried mushrooms or mushroom components is preferred, but usually mushrooms or mushroom components are used which are mechanically comminuted before extraction. All the grinding methods known to the person skilled in the art are suitable here, for example crushing with a mortar.
  • the extraction is usually carried out at 20 to 100 ° C, preferably at 20 to 85 ° C, in particular either at the boiling point of the solvent used or at room temperature.
  • the extraction takes place under an inert gas atmosphere to avoid oxidation of the ingredients of the extract.
  • the extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc.
  • the crude fractions obtained can optionally be subjected to further conventional steps, such as purification, concentration and / or decolorization. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients.
  • the extraction can be carried out to any desired degree of extraction, but is usually carried out until exhaustion.
  • the present invention includes the knowledge that the extraction conditions and the yields of the final extracts can be selected depending on the desired field of use. If desired, the extracts can then be subjected to spray or freeze drying, for example.
  • the amount of mushroom extracts used in the preparations mentioned depends on the type of application of the extracts and on the concentration of the individual ingredients.
  • the total amount of the mushroom extract contained in the preparations according to the invention is generally 0.001 to 30% by weight, preferably 0.05 to 5% by weight, in particular 0.03 to 1% by weight, based on the final preparation , with the proviso that the amounts given with water and possibly other auxiliaries and additives add up to 100% by weight.
  • the extracts according to the invention can also be incorporated into or connected to any other applicable cosmetic vector, for example film-forming agents, liposomes, micro and nanocapsules, micro and nanoparticles.
  • the invention accordingly furthermore relates to cosmetic compositions comprising an extract from Myccorhiza mushrooms in encapsulated form or absorbed on a carrier.
  • Cosmetic preparations or agents in the sense of the invention are skin care products. These care products include stimulating, healing and building effects for the skin. Care products within the meaning of the invention are preferably those care products which have a stimulating effect on the skin cells and their functions and also have a constructive effect on the skin and preventive action against environmental influences on the skin. Furthermore, care products are preferably to be understood within the meaning of the invention as those which can either improve or cure various skin diseases with their different effects on the appearance and function of the skin.
  • the preparations according to the invention have an excellent skin-care effect with high skin tolerance. In addition, they show good stability, in particular against oxidative decomposition of the products.
  • the extract can be worked into suitable cosmetic vectors such as liposomes, macro, micro and nanocapsules, macro, micro and nanoparticles and other analogous and known forms.
  • the aforementioned extracts can be used for skin care and hygiene applications (products for the face and body, day or night cosmetics, sunscreen strengthening, regenerating products, anti-wrinkle cosmetics, slimming products, anti-aging agents) in the form of preparations , such as lotions or shampoos, creams, foaming agents, soaps, sticks, gels, hydrogels, spray agents, emulsions, protective agents, repairing, softening, film-forming and photo-protective agents; Products for permanent waves and for coloring hair.
  • skin care and hygiene applications products for the face and body, day or night cosmetics, sunscreen strengthening, regenerating products, anti-wrinkle cosmetics, slimming products, anti-aging agents
  • preparations such as lotions or shampoos, creams, foaming agents, soaps, sticks, gels, hydrogels, spray agents, emulsions, protective agents, repairing, softening, film-forming and photo-protective agents.
  • the above-mentioned extracts can be used for the production of cosmetic agents, such as hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat masses, stick preparations, powders or ointments, but primarily products for face and body, day or night cosmetics, sunscreens, strengthening, regenerating products, anti-wrinkle cosmetics, slimming products and agents against aging processes.
  • These agents can also be used as further auxiliaries and additives, mild surfactants, oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers.
  • Ren polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, UV light protection factors, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, self-tanners, tyrosine inhibitors (depigmenting agents, solubilizers, hydrotrope) Contain preservatives, perfume oils, dyes and the like.
  • Anionic, nonionic, cationic and / or amphoteric or amphoteric surfactants can be present as surface-active substances, the proportion of the agents usually being about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight.
  • anionic surfactants are soaps, alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, fatty acid ether sulfates, hydroxymate sulfate ethersulfates, hydroxymate sulfate ethersulfates, hydroxymate sulfate ethersulfates, Mono- and dialkylsulf
  • anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or especially glucoramide acid vegetable derivatives, fatty acid glucoronic acid protein derivatives, and fatty acid glucoramides Wheat base), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazoliniumbetaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, ether carboxylic acids ligoglucoside, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates, the latter preferably based on wheat proteins.
  • Suitable oil bodies are, for example, Guerbet alcohols preferably containing 8 to 10 carbon atoms, esters based on fatty alcohols having 6 to 18, of linear C6-C22 fatty acids with linear or branched C 6 -C 22 -fatty alcohols or esters of branched C 6 -C ⁇ 3 - Carboxylic acids with linear or branched C 6 -C 22 fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, myristyl behenate, myristyl lerucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl
  • esters of linear C 6 -C 22 fatty acids with branched alcohols in particular 2-ethylhexanol
  • esters of C 18 -C 38 alkylhydroxycarboxylic acids with linear or branched C 6 -C 2 fatty alcohols in particular dioctyl malates
  • esters of linear ones and / or branched fatty acids with polyhydric alcohols such as propylene glycol, dimer diol or Trirner triol
  • polyhydric alcohols such as propylene glycol, dimer diol or Trirner triol
  • Guerbet alcohols triglycerides based on Ce fatty acids
  • esters of C 6 -C 22 fatty alcohols and or Guerbet alcohols with aromatic carboxylic acids especially benzoic acid, esters of C 2 -C 12 dicarboxylic acids with linear or branched
  • Suitable emulsifiers are, for example, nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (eg sorbitol), alkyl glucosides (eg methyl glucoside, butyl glucoside, lauryl glucoside) as well as polyglucosides (eg cellulose) saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate; Polymer emulsifiers, e.g. Pemulen types (TR-1, TR-2) from Goodrich;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. C 12/18 - fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic preparations.
  • Alkyl and / or alkenyl oligoglycosides their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms. With regard to the glycoside residue, both monoglycosides in which a cyclic sugar nest is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to approximately 8 are suitable. The degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid, Isostearinklarediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolklaremoglycerid, Ricinolklarediglyce- chloride, Linolklaremonoglycerid, Linolklarediglycerid, Linolenchuremonogiycerid, linolenic klarediglycerid, Erucaklaremonoglycerid, Erucaklakladiglycerid, Weinklaremonoglycerid, Weinklarediglycerid, Citronenklamonoglycerid, Citronendiglycerid, ⁇ pfelklaremo- noglycerid, Malic acid diglyceride and their technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1
  • sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan come diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan dioleate, trioleate, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, sorbitan tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitan sesquitarate, sorbitan ditartrate, sorbitan tritarate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan citrate, sorb
  • polyglycerol esters are polyglyceryl-2 dipolyhydroxystearate (Dehymuls® PGPH), polyglycerol-3-diisostearate (Lameform® TGI), polyglyceryl-4 isostearate (Isolan® GI 34), polyglyceryl-3 oleates, diisostearoyl polyglyce ryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether ( Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate
  • Typical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Amphoteric and cationic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Amphoteric and cationic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-AJJcyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylammopropyldimethylammoniumglycinate, and 2-alkylmethyl-carboxylate -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the coconut acylaminoethyl hydroxyethyl carboxymethyl glycinate.
  • betaines such as the N-AJJcyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium
  • fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine is particularly preferred.
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C 8/18 alkyl or acyl group, contain at least one free amino group and at least one - COOH or -SO 3 H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group .
  • particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 12/18 acyl sarcosine.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, that is to say solid or liquid vegetable or animal products which essentially consist of mixed glycerol esters of higher fatty acids, and waxes include natural waxes, such as candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax and sugar ear wax , Ouricury wax, montan wax, beeswax, shellac wax, walrus, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, micro waxes; chemically modified waxes (hard waxes), such as montan ester waxes, sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as polyalkylene waxes and polyethylene glycol colwaxes in question.
  • natural waxes such as candelilla wax, carnauba wax, Japanese wax
  • lecithins In addition to fats, fat-like substances such as lecithins and phospholipids can also be used as additives.
  • lecithins are those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC). Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • Pearlescent waxes that can be used are, for example: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, Polyacrylates (e.g. Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinylpyrrolidone.
  • aerosil types hydrophilic silicas
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose,
  • Bentone® Gel VS-5PC which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate
  • Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, such as a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpynolidone vinylimidazole polymers, such as Luviquat® (BASF), Condensation products of polyglycols and amines, quaternized collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as amodimethicones, copolymers of adipic acid and dimethyldiethylroxin (hydroxymethylaminohydroxin) -dimethylaminohydroxin Sandoz), copolymers of acrylic acid with dimethyl
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpynolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornylacrylate copolymers, methyl vinyl ether, maleic anhydride copolymers and their esters, crosslinked acrylics and their polyols, non-crosslinked acrylic and amidopropyltrimethylammomum chloride / acrylate copolymers, octylacrylamide / methyl methacrylicate / tert-butylaminoemyl methacrylate / 2-hyroxroxypropyl methacrylate copolymers, polyvinylpynolidone, vinylpynolidone / vinyl acetate copolymers, vinylpynolidone / vinyl acrylate and vinyl acrylate / vinyl acrylate
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. Anserine), carotenoids, caroline (e.g.
  • ⁇ -carotene, ß-carotene, lycopene) and their derivatives chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g.
  • thioredoxin glutathione, Cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, penta-, hexa-, himinath) in very low tolerable doses (e.g.
  • chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, biliary extracts, bilirubin , Biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g.
  • biogenic active substances include tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, ⁇ -glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudo-ceramides, meaning ceramides, To understand plant extracts and vitamin complexes.
  • deodorants counteract, mask or eliminate body odors.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers. Anti-germ agents
  • germ-inhibiting agents such as.
  • esterase inhibitors include sterolsulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterin, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, Diethyl glutarate, adipic acid, monoethyl adipate, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester and zinc glycinate.
  • sterolsulfates or phosphates such as, for example, lanosterol, cholesterol, campesterin, stigmasterol and sitosterol sulfate or phosphate
  • dicarboxylic acids and their esters such as, for example, glutaric acid, glutaric acid mono
  • Suitable as odor absorbers are substances which absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixers", such as, for example, the main component. B. extracts of Labdanum or Styrax or agreed abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance.
  • Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and twigs as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil.
  • Antiperspirants reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor.
  • Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
  • non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
  • Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients.
  • suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. B. with 1,2-propylene glycol.
  • customary oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:
  • water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusting agents, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as Xanthan gum, hydroxyethyl cellulose, polyvinylpynolidone or high molecular weight polyethylene oxides.
  • Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-trimythylpentyl) -2- (1H) -pyridinone monoethanolamine salt
  • Baypival® (climbazole), Ketoconazol®, (4-acetyl-1 - ⁇ - 4- [2- (2.4-dichlorophenyl) r-2- (lH-imidazol-l-ylmethyl) -l, 3-dioxylan-c- 4-ylmethoxyphenyl ⁇ piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal, Schwefelpolyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid monoethanolamide sulfosuccinate Na salt Mo, Lamepon® UD (protein undec
  • Montmorillonites, clay minerals, pemulene and alkyl-modified carbopol types can serve as swelling agents for aqueous phases.
  • Possible insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl butyl acetylaminopropionate
  • Dihydroxyacetone is suitable as a self-tanner.
  • tyrosine inhibitors which prevent the formation of melanin and are used in depigmenting agents are arbutin, ferulic acid, kjic acid, coumaric acid and ascorbic acid (vitamin C).
  • Alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons; technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;
  • Methyl compounds such as, in particular, trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides in particular those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;
  • Sugar alcohols with 5 to 12 carbon atoms such as sorbitol or mannitol, sugars with 5 to 12 carbon atoms, such as glucose or sucrose;
  • Dialcohol amines such as diethanolamine or 2-amino-l, 3-propanediol.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme) ), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (Galbanum, Elemi, Benzoe, Mynhe, Olibanum, Opoponax).
  • Typical synthetic fragrance compounds are product esters, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linylbenzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexylpropylate propylate, pentylate propylate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, ⁇ -isomethylionone and methylcedryl ketone
  • the alcohols Anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpinol
  • the hydrocarbons mainly include terpenes and balms.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin.
  • the dyes which can be used are those which are suitable and approved for cosmetic purposes. Examples are culinary red A (CI 16255), patent blue V (CI42051), indigotine (CI73015), chlorophyllin (CI75810), quinoline yellow (CI47005), titanium dioxide (CI77891), indanthrene blue RS (CI 69800) and madder varnish (CI 58000). Lummol can also be contained as luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • the purpose of the following experiments was to determine the regenerative and revitalizing properties of an aqueous extract of the fungus Laccaria laccata on human fibroblast cultures in vitro.
  • FCS fetal calf serum
  • Lipolysis is the removal of triglycerides stored in adipocytes by the enzyme triglyceride lipase.
  • the triglyceride lipase breaks down the triglycerides into free fatty acids and glycerin. These metabolic products are removed through the bloodstream. The free fatty acids can then be converted into energy by muscle cells.
  • the content of released glycerol (ie the activity of lipolysis) was determined spectoscropically in the supernatant medium according to the method of Carpene C. et al. (Carpene C. et al.; Discrimination of the adrenergiques a potentialite 2 par l'etude de la lipolyse sur des adipocytes de hamster; J. Pharmacol. (Paris), 12, 2, 219-224 (1981)). Each extract was tested against the reference substances (theophylline and isoprenaline). This test was carried out on two to six different samples of human adipocytes. The results were presented as the average value of the released glycerol as a percentage improvement compared to the control test (the control test corresponds to 0%).
  • the release of glycerin was moderately activated by the aqueous extract. So the aqueous extract has shown a potential for stimulating lipolysis and thus for a slimming effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of an extract on the basis of mycorrhiza fungi in the production of cosmetic agents and to cosmetic preparations that contain an extract from mycorrhiza fungi. The extract from mycorrhiza fungi is suitable for use in the care of sensitive skin and has excellent cosmetic properties, it serves for example to protect the skin from aging and has a positive cell-protecting influence on oxidative stress, harmful environmental pollutants and damages caused by UV radiation.

Description

Verwendung eines Extraktes aus Mycorrhiza-Pilzen Use of an extract from mycorrhizal mushrooms

Gebiet der ErfindungField of the Invention

Die vorliegende Erfindung bezieht sich auf das Gebiet der Kosmetik. Ihre Zielsetzung besteht in der Verwendung eines Extraktes von Mycorrhiza-Pilzen. Ein weiterer Gegenstand der Erfindung sind kosmetische Zubereitungen, die einen derartigen Extrakt enthalten.The present invention relates to the field of cosmetics. Your goal is to use an extract of mycorrhizal mushrooms. The invention further relates to cosmetic preparations which contain such an extract.

Stand der TechnikState of the art

Pilze sind allgemein bekannt als wertvolle Wirkstofflieferanten für die kosmetische und pharmazeutische Industrie. In der Kosmetik werden häufig Saprophyten oder pathogene pflanzliche Parasiten wie beispielsweise Grifola frondosa oder Lentinus edodes eingesetzt, da diese einfach zμ kultivieren sind und eine Gewinnung in ausreichendem Maße mit geringen Mitteln ermöglichen.Mushrooms are generally known as valuable suppliers of active ingredients for the cosmetic and pharmaceutical industries. Saprophytes or pathogenic plant parasites such as, for example, Grifola frondosa or Lentinus edodes are often used in cosmetics, since they are simply cultivated zμ and can be obtained to a sufficient extent with minimal resources.

Mycorrhiza-Pilze, insbesondere Ectomycorrhiza-Pilze gehen mit Wirtspflanzen eine für beide Seiten vorteilhafte Symbiose ein. Sie gehören zu den Basidiomycotina oder Ascomycoti- na (Trüffel).Mycorrhiza fungi, in particular ectomycorrhiza fungi, enter into a mutually beneficial symbiosis with host plants. They belong to the Basidiomycotina or Ascomycotina (truffle).

In Wäldern der gemäßigten und nördlichen Breiten sind bis zu 95 % der kurzen Baum- und Gebüschwurzeln mit Ectomycorrhiza-Pilzen besetzt. Sie haben einen positiven Einfluss auf das Pflanzenwachstum in natürlichen und forst- oder agrarwirtschaftlichen Ökosystemen.In forests of the temperate and northern latitudes, up to 95% of the short tree and shrub roots are covered with ectomycorrhiza fungi. They have a positive impact on plant growth in natural and forestry or agricultural ecosystems.

Ein wesentlicher Faktor der Symbiose ist der gegenseitige Austausch von Nährstoffen unter den Symbionten. Die Pilze erhalten Kohlenhydrate von ihren Wirtspflanzen und regulieren im Austausch die Aufnahme der Wirte von Wasser und Nährstoffen wie Phosphaten und Aminosäuren. Für den Lebenscyclus der Pilze ist diese Symbiose notwendig.An essential factor of the symbiosis is the mutual exchange of nutrients among the symbionts. The fungi receive carbohydrates from their host plants and, in exchange, regulate the absorption of the hosts by water and nutrients such as phosphates and amino acids. This symbiosis is necessary for the life cycle of the mushrooms.

Das japanische Dokument JP 09227333 offenbart kosmetische Mittel mit Extrakten von Basidiomyceten der Familie der Boletaceae, die einen hautverschönernden und feuchtig- keitsspendenden Effekt aufweisen.Japanese document JP 09227333 discloses cosmetic compositions with extracts from Basidiomycetes of the Boletaceae family, which have a skin-beautifying and moisturizing effect.

Neben den feuchtigkeitsspendenden Eigenschaften werden für andere Pilze verwandter Familien hautpflegende, vor Alterserscheinungen schützende, oder revitalisierende Eigenschaften untersucht. Die Zusammensetzung eines späteren Produktes soll dabei zusätzlich eine optimale dermatologische Verträglichkeit besitzen, so dass auch empfindliche Verbraucher nicht mit Irritationen reagieren. Darüber hinaus sollten die Mittel jedoch auch weitere Funktionen erfüllen, die gleichzeitig die technischen Eigenschaften des kosmetischen Produktes, wie Lagerstabilität, Lichtstabilität und Formulierbarkeit positiv beeinflussen oder zumindest nicht verschlechtern.In addition to the moisturizing properties, skin-caring, aging-protecting, or revitalizing properties are being investigated for other families of related families. The composition of a later product should also have optimal dermatological compatibility, so that even sensitive consumers do not react with irritation. In addition, however, the agents should also perform other functions which simultaneously affect the technical properties of the cosmetic product, such as storage stability, light stability and formulability positively influence or at least not deteriorate.

Die komplexe Aufgabe der vorliegenden Patentanmeldung hat darin bestanden, neue Wirkungen von bereits bekannten Pilzen oder verwandten Arten zu finden und die Verwendung dieser Extrakte in kosmetischen Mitteln zu ermöglichen, die sich durch eine hohe Verträglichkeit auch für empfindliche Haut auszeichnen und zusätzlich eine gute physiko-chemische Stabilität aufweisen.The complex task of the present patent application was to find new effects of already known fungi or related species and to enable the use of these extracts in cosmetic products which are also well tolerated for sensitive skin and also have good physico-chemical properties Have stability.

Beschreibung der ErfindungDescription of the invention

Gegenstand der vorliegenden Erfindung ist die Verwendung eines Extraktes aus Mycorrhiza- Pilzen zur Herstellung kosmetischer Zubereitungen für die lokale Anwendung auf der Haut, Kopfhaut, den Epithelanhanggebilden und/oder den Schleimhäuten.The present invention relates to the use of an extract from mycorrhiza fungi for the production of cosmetic preparations for topical use on the skin, scalp, the epithelial appendages and / or the mucous membranes.

Ein weiterer Gegenstand der Erfindung sind kosmetische Zubereitungen, enthaltend einen Extrakt der Mycorrhiza-Pilze.Another object of the invention are cosmetic preparations containing an extract of the mycorrhizal fungi.

In einer besonderen Ausführungsform der vorliegenden Erfindung sind die Mycorrhiza-Pilze Ectomycorrhiza-Pilze. Besonders bevorzugt ist der Pilz Laccaria laccata. Insbesondere ist die Verwendung eines wässrigen Extraktes von Laccaria laccata eine bevorzugte Ausfuhrungs- form der vorliegenden Erfindung.In a special embodiment of the present invention, the mycorrhiza fungi are ectomycorrhiza fungi. The fungus Laccaria laccata is particularly preferred. In particular, the use of an aqueous extract from Laccaria laccata is a preferred embodiment of the present invention.

Es wurde überraschender Weise festgestellt, dass die Extrakte von Mycorrhiza-Pilzen bei lokaler Anwendung auf der Haut, der Kopfhaut, den Epithelanhanggebilden und/oder den Schleimhäuten besondere biologische Wirkungen hervorrufen und über eine sehr gute Toleranz verfügen. Die Verwendung von mindestens einer aus Mycorrhiza-Pilzen extrahierten Fraktion als Wirkstoff, alleine oder in Verbindung mit mindestens einem anderen Wirkstoff, in einer Zusammensetzung oder einem kosmetischen Erzeugnis bei lokaler Anwendung auf der Haut, Kopfhaut, den Epithelanhanggebilden und/oder den Schleimhäuten zeigt regenerative Wirkungen, Anti-Reizwirkungen, Anti-Aging Effekte, UV-Schutzwirkung, anti- Protease Aktivität, anti-alpha-5-Reductase Aktivität, schützende Wirkung gegen oxidativen Stress und anti-inflammatorische Aktivitäten, sowie lipolytische Aktivit an humanen Fettzellen.It has surprisingly been found that the extracts of mycorrhizal fungi when used locally on the skin, the scalp, the epithelial appendages and / or the mucous membranes produce particular biological effects and have a very good tolerance. The use of at least one fraction extracted from mycorrhizal fungi as an active ingredient, alone or in conjunction with at least one other active ingredient, in a composition or a cosmetic product when used locally on the skin, scalp, epithelial appendages and / or the mucous membranes shows regenerative effects , Anti-irritant effects, anti-aging effects, UV protection, anti-protease activity, anti-alpha-5-reductase activity, protective effect against oxidative stress and anti-inflammatory activities, as well as lipolytic activity on human fat cells.

Die Extrakte von Mycorrhiza-Pilzen zeichnen sich besonders zur vorbeugenden und heilenden Behandlung empfindlicher Hauttypen und als Sonnenschutzmittel aus. Die Extrakte von Mycorrhiza-Pilzen wirken auf der Kopfhaut gegen Alopecia. Sie werden hervorragend vertragen. Ein Gegenstand der Erfindung ist daher die Verwendung von Extrakten der Mycorrhiza-Pilze in kosmetischen und/oder dermatologischen Zubereitungen für empfindliche Haut.The extracts of mycorrhizal mushrooms are particularly suitable for the preventive and healing treatment of sensitive skin types and as a sunscreen. Mycorrhizal mushroom extracts work on the scalp against alopecia. They are well tolerated. The invention therefore relates to the use of extracts of the mycorrhizal fungi in cosmetic and / or dermatological preparations for sensitive skin.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in kosmetischen und/oder dermatologischen Mitteln mit UV-Schutzwirkung.Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic and / or dermatological agents with UV protection.

Als Sonnenschutzmittel bzw. UV-Lichtschutzfaktoren im Sinne der Erfindung werden Lichtschutzmittel bezeichnet, die für den Schutz der menschlichen Haut gegenüber schädigenden Einflüssen der direkten und indirekten Strahlung der Sonne nützlich sind. Die für die Hautbräunung verantwortliche Ulfraviolettstrahlung der Sonne unterteilt man in die Abschmtte UV-C (Wellenlängen 200-280 um), UV-B (280-315 nm) und UV-A (315-400 nm).Sunscreens or UV light protection factors in the sense of the invention are light protection agents which are useful for protecting human skin against the damaging effects of direct and indirect radiation from the sun. The sun's ulfraviolet radiation, which is responsible for tanning the skin, is divided into UV-C (wavelengths 200-280 µm), UV-B (280-315 nm) and UV-A (315-400 nm).

Die Pigmentierung normaler Haut unter dem Einfluss der Sonnenstrahlung, d.h. die Bildung von Melaninen, wird durch UV-B und UV-A unterschiedlich bewirkt. Bestrahlung mit UV-AStrahlen („langwelligem UV") hat die Dunkelung der in der Epidermis bereits vorhandenen Melanin-Körper zur Folge, ohne dass schädigende Einflüsse zu erkennen sind. Anders bei dem sog. „kurzwelligen UV" (UV-B). Dieses bewirkt die Entstehung von sog. Spätpigment durch Neubildung von Melanin-Körnern. Ehe jedoch das (schützende) Pigment gebildet ist, unterliegt die Haut der Einwirkung der ungefilterten Strahlung, die -je nach Expositionsdauer - zur Bildung von Hautrötungen (Erythemen), Hautentzündungen (Sonnenbrand) und gar Brandblasen führen kann.The pigmentation of normal skin under the influence of solar radiation, i.e. the formation of melanins is caused differently by UV-B and UV-A. Irradiation with UV-A rays ("long-wave UV") results in the darkening of the melanin bodies already present in the epidermis, without any harmful effects being recognizable. This is different with the so-called "short-wave UV" (UV-B). This causes the development of so-called late pigment through the formation of new melanin grains. However, before the (protective) pigment is formed, the skin is exposed to the unfiltered radiation, which - depending on the duration of exposure - can lead to the formation of reddened skin (erythema), skin inflammation (sunburn) and even burn blisters.

Als UV-Absorber oder Lichtfilter (Lichtschutzfaktoren), die also die UV-Strahlung in unschädliche Wärme umwandeln, werden die erfmdungsgemäßen Extrakte von Mycorrhiza- Pilzen zusätzlich in Kombination mit weiteren Sonnenschutzmitteln bzw. UV- Lichtschutzfaktoren eingesetzt, um eine synergistische Wirkung zu erreichen.The extracts of mycorrhiza fungi according to the invention are additionally used in combination with other sunscreens or UV light protection factors as UV absorbers or light filters (light protection factors), which convert the UV radiation into harmless heat, in order to achieve a synergistic effect.

UV-LichtschutzfaktorenUV protection factors

Die neben den Pilzextrakten eingesetzten weiteren UV- Lichtschutzfaktoren sind beispielsweise bei Raumtemperatur flüssig oder kristallin vorliegende organische Substanzen (Licht- schutzfilter), die in der Lage sind, ultraviolette Strahlen zu absorbieren und die aufgenommene Energie in Form längerwelliger Strahlung, z.B. Wärme wieder abzugeben. UVB-Filter können öllöslich oder wasserlöslich sein. Als öllösliche Substanzen sind z.B. zu nennen:The other UV light protection factors used in addition to the mushroom extracts are, for example, liquid or crystalline organic substances (light protection filters) at room temperature which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again. UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:

> 3-Benzylidencampher bzw. 3-Benzylidennorcampher und dessen Derivate, z.B. 3-(4- Methylbenzyliden)campher wie in der EP 0693471 Bl beschrieben; 4-Aminobenzoesäurederivate, vorzugsweise 4-(Dimethylamino)benzoesäure-2- ethylhexylester, 4-(Dimethylamino)benzoesäure-2-octylester und 4- (Dimethylamino)benzoesäureamylester;> 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives, e.g. 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1; 4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;

> Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester, 4- Methoxyzimtsäurepropylester, 4-Methoxyzimtsäureisoarnylester 2-Cyano-3,3- phenylzimtsäure-2-ethylhexylester (Octo- crylene);> Esters of cinnamic acid, preferably 4-methoxycinnamic acid-2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isocyanate ester 2-cyano-3,3- 2-ethylhexyl phenylcinnamate (octocrylene);

> Ester der Salicylsäure, vorzugsweise Salicylsäure-2-ethylhexylester, Salicylsäure-4- isopropylbenzylester, Salicylsäurehomomenthylester;> Esters of salicylic acid, preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;

> Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2- Hydroxy-4-methoxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzophenon;> Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;

> Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzmalonsäuredi-2- ethylhexylester;> Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzmalonate;

> Triazinderivate, wie z.B. 2,4,6-Trianilino-(p-carbo-2'-ethyl- -hexyloxy)-l,355-triazin und Octyl Triazon, wie in der EP 0818450 AI beschrieben oder Dioctyl Butamido Triazone (Uvasorb® HEB);> Triazine derivatives, such as 2,4,6-trianilino- (p-carbo-2'-ethyl-hexyloxy) -l, 3 5 5-triazine and octyl triazone, as described in EP 0818450 AI or dioctyl butamido triazone ( Uvasorb® HEB);

> Propan-l,3-dione, wie z.B. l-(4-tert.Butylphenyl)-3-(4'methoxyphenyl)propan-l,3-dion;> Propane-l, 3-dione, e.g. l- (4-tert-butylphenyl) -3- (4'methoxyphenyl) propane-l, 3-dione;

> Ketotricyclo(5.2.1.0)decan-Derivate, wie in der EP 0694521 Bl beschrieben.> Ketotricyclo (5.2.1.0) decane derivatives, as described in EP 0694521 B1.

Als wasserlösliche Substanzen kommen in Frage:Possible water-soluble substances are:

> 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alky- lammonium-, Alkanolammonium- und Glucammoniumsalze;> 2-phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts;

> Sulfonsäurederivate von Benzophenonen, vorzugsweise 2-Hydroxy-4- methoxybenzophenon-5-sulfonsäure und ihre Salze; Sulfonsäurederivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornylidenme- thyl)benzol- sulfonsäure und 2-Methyl-5-(2-oxo-3-bornyliden)sulfonsäure und deren Salze.> Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts; Sulfonic acid derivatives of 3-benzylidene camphor, e.g. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bornylidene) sulfonic acid and their salts.

Als typische UVA-Filter kommen insbesondere Derivate des Benzoyhnethans in Frage, wie beispielsweise l-(4'-tert.Butylphenyl)-3-(4'-methoxyphenyl)propan-l,3-dion, 4-tert.-Butyl-4'- methoxydibenzoylmethan (Parsol 1789), l-Phenyl-3-(4'-isopropylphenyl)-propan-l,3-dion sowie Enaminverbindungen, wie beispielsweise beschrieben in der DE 19712033 AI (BASF). Die UV-A und UV-B-Filter können selbstverständlich auch in Mischungen eingesetzt werden. Neben den genannten löslichen Stoffen kommen für diesen Zweck auch unlösliche Lichtschutzpigmente, nämlich feindisperse Metalloxide bzw. Salze in Frage. Beispiele für geeignete Metalloxide sind insbesondere Zinkoxid und Titandioxid und daneben Oxide des Eisens, Zirkoniums, Siliciums, Mangans, Aluminiums und Cers sowie deren Gemische. Als Salze können Silicate (Talk), Bariumsulfat oder Zinkstearat eingesetzt werden. Die Oxide und Salze werden in Form der Pigmente für hautpflegende und hautschützende Emulsionen verwendet. Die Partikel sollten dabei einen mittleren Durchmesser von weniger als 100 nm, vorzugsweise zwischen 5 und 50 nm und insbesondere zwischen 15 und 30 nm aufweisen. Sie können eine sphärische Form aufweisen, es können jedoch auch solche Partikel zum Einsatz kommen, die eine ellipsoide oder in sonstiger Weise von der sphärischen Gestalt abweichende Form besitzen. Die Pigmente können auch oberflächenbehandelt, d.h. hydrophilisiert oder hydrophobiert vorliegen. Typische Beispiele sind gecoatete Titandioxide, wie z.B. Titandioxid T 805 (Degussa) oder Eusolex® T2000 (Merck). Als hydrophobe Coatingmittel kommen dabei vor allem Silicone und dabei speziell Trialkoxyoctylsilane oder Dimethicone in Frage. In Sonnenschutzmitteln werden bevorzugt sogenannte Mikro- oder Nanopigmente eingesetzt. Vorzugsweise wird mikronisiertes Zinkoxid verwendet.Derivatives of benzoyhanethane, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl-4, are particularly suitable as typical UVA filters '- methoxydibenzoylmethane (Parsol 1789), l-phenyl-3- (4'-isopropylphenyl) propane-l, 3-dione and enamine compounds, as described for example in DE 19712033 AI (BASF). The UV-A and UV-B filters can of course also be used in mixtures. In addition to the soluble substances mentioned, insoluble light protection pigments, namely finely dispersed metal oxides or salts, are also suitable for this purpose. Examples of suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof. Silicates (talc), barium sulfate or zinc stearate can be used as salts. The oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions. The particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or a shape which differs in some other way from the spherical shape. The pigments can also be surface-treated, ie hydrophilized or hydrophobized available. Typical examples are coated titanium dioxides, such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or dimethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in Mitteln zur vorbeugenden oder heilenden Behandlung von Alterserscheinungen der Haut, Kopfhaut, den Epithelanhanggebilden und/oder den Schleimhäuten. Eine andere Bezeichnung für diese Art der Pflegemittel ist auch anti-ageing Mittel. Zu diesen Alterserscheinungen zählen beispielsweise jede Art der Fältchen- und Faltenbildung. Die Behandlungen schließen eine Verlangsamung von Altersprozessen der Haut mit ein. Die Alterserscheinungen können die unterschiedlichsten Ursachen aufweisen. Insbesondere sind diese Alterserscheinungen auf Grund einer durch UV-Strahlung induzierten Schädigung der Haut verursacht. In einer besonderen Ausfuhrungsform der Erfindung werden diese Pflegemittel zur Behandlung von durch UV-Strahlung induzierten Alterserscheinungen der Haut eingesetzt.Another object of the invention is the use of extracts from mycorrhizal fungi in agents for the preventive or curative treatment of signs of aging of the skin, scalp, the epithelial appendages and / or the mucous membranes. Another name for this type of care product is anti-aging. These signs of aging include any type of wrinkles and wrinkles. Treatments include slowing skin aging. The signs of aging can have a variety of causes. In particular, these signs of aging are caused by damage to the skin induced by UV radiation. In a special embodiment of the invention, these care products are used to treat signs of aging in the skin induced by UV radiation.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in kosmetischen Mitteln mit anti-Protease Aktivität, insbesondere mit anti-Collagenase und/oder anti-Elastase Aktivtät. Diese Proteasen (Collagenase und die unterschiedlichen E- lastasen) katalysieren die Fragmentierung und Zerstörung der dermalen Makromoleküle wie Proteoglycan, Collagen und Elastin und führen dadurch zur Alterung der Haut und zu den Effekten der natürlichen Hautalterung nach UV-Strahlung.Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic products with anti-protease activity, in particular with anti-collagenase and / or anti-elastase activity. These proteases (collagenase and the different elastases) catalyze the fragmentation and destruction of the dermal macromolecules such as proteoglycan, collagen and elastin and thus lead to aging of the skin and to the effects of natural skin aging after UV radiation.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten der Mycorrhiza- Pilze als kosmetisches anti-inflammatorisches Mittel. Als anti-inflarnmatorisches Mittel sind im Sinne der Erfindung die Art der Pflegemittel zu verstehen, die eine Entzündung der Haut heilen können oder die einer Entzündung vorbeugen können. Die Entzündungen können dabei die unterschiedlichsten Ursachen aufweisen. Insbesondere können Entzündungen behandelt werden, die durch UV-Strahlung, Hautverunreinigungen oder bakteriell wie hormonell bedingte Hautveränderungen, z. B. Akne induziert werden.Another object of the invention is the use of extracts of the mycorrhiza fungi as a cosmetic anti-inflammatory agent. In the context of the invention, anti-inflammatory agents are to be understood as the type of care products which can cure inflammation of the skin or which can prevent inflammation. The inflammation can have a variety of causes. In particular, inflammation can be treated which is caused by UV radiation, skin impurities or bacterial or hormonal skin changes, e.g. B. Acne can be induced.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in schützenden und aufbauenden Pflegemitteln zur Stimulierung des Metabolismus der Hautzellen mit revitalisierenden, regenerierende, feuchthaltenden und/oder reaktivierenden Aktivitäten für die Haut, der Kopfhaut, den Epithelanhanggebilden und/oder den Schleimhäuten.Another object of the invention is the use of extracts from mycorrhiza fungi in protective and restorative care products for stimulating the metabolism of the skin cells with revitalizing, regenerating, moisturizing and / or reactivating Activities for the skin, scalp, epithelial appendages and / or mucous membranes.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in zellschützenden Mitteln zur Stärkung der Immunabwehr der Haut. Diese Art der Verwendung dieser Pflegemittel wirkt positiv beispielsweise gegen den negativen Einfluss der Umweltverschmutzung auf Haut und/oder Haare, gegen Umweltgifte oder oxidativen Stress, indem sie die natürlichen Funktionen der Haut und/oder Haare reaktivieren und die Haut und/oder Haare widerstandsfähiger machen und damit die Immunabwehr stärken.Another object of the invention is the use of extracts from mycorrhiza fungi in cell-protecting agents to strengthen the immune defense of the skin. This type of use of these care products has a positive effect, for example, against the negative influence of environmental pollution on the skin and / or hair, against environmental toxins or oxidative stress, by reactivating the natural functions of the skin and / or hair and making the skin and / or hair more resistant and thus strengthen the immune system.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten aus Mycorrhiza- Pilzen in kosmetischen Mitteln zur Stimulierung der Synthese von dermalen Makromolekülen ausgewählt aus der Gruppe, die gebildet wird aus Collagen, Elastin, Fibronectin, Proteoglyca- nen, Hyaluronsäure und deren Salzen.Another object of the invention is the use of extracts from mycorrhizal fungi in cosmetic products to stimulate the synthesis of dermal macromolecules selected from the group consisting of collagen, elastin, fibronectin, proteoglycans, hyaluronic acid and their salts.

Dermale MakromoleküleDermal macromolecules

Als dermale Makromoleküle sind im Sinne der Erfindung prinzipiell alle Makromoleküle zu verstehen, die als Bestandteile der Haut entweder in der Basalmembran zwischen Dennis und Epidermis oder in der Dennis und Epidermis direkt zu finden sind. Es handelt sich im Besonderen um Verbindungen die ausgewählt sind aus der Gruppe, die gebildet wird von Collagen, Elastin, Proteoglycanen, Fibronectinen und Hyaluronsäure und deren Salze. Collagen besteht aus Proteinfasern und kommt in menschlicher Haut in drei verschiedenen Typen (Typ I, ITf und IV) vor. Im Collagen sind die einzelnen Polypeptidketten, die jeweils viel von der Aminosäure Prolin und als jeden dritten Rest Glycin, umeinander zu einer Tripelhelix gewunden. Die Collagenfasern werden als Tropokollägen in den Fibroblasten synthetisiert und in die extrazelluläre Matrix ausgeschleust. Die erfindungsgemäße Stimulierung der Synthese des Collagens führt zu einer Erhöhung der Produktion an Collagen und damit zu einer erhöhten intermolekularen Verfestigung der Dennis und dadurch zu einer straffer erscheinenden Haut. Das Elastin ist ebenfalls ein faserartiges Protein. Hierbei handelt es sich um unstrukturierte kovalent quervernetzte Polypeptidketten, die ein gummiähnliches elastisches Material bilden. Das Elastin wird nach der Synthese in den Hautzellen in die extrazelluläre Matrix ausgeschleust. Die erfindungsgemäße Stimulierung der Synthese der Elastin-Polypeptidketten führt zu einer Erhöhung der Produktion an Elastin und damit zu einer Erhöhung der Elastizität der Haut. Die Proteoglycane bestehen wie die Glycoproteine aus Kohlenhydraten und aus Proteinen, bei den Proteoglycanen überwiegt jedoch der Anteil an Polysacchariden. Die Proteoglycane der Haut enthalten Dermatansulfat. Es lagern sich ca. 140 solcher Proteoglycane mit Hilfe kleinerer Proteine (Link-Proteine) nichtkovalent an eine Hyaluronsäure-Kette zu Molekül- Aggregaten mit einer mittleren Molmasse von ca. 2 Mio. an. Die durch ihr Wasserbindevermögen ausgezeichneten polyanionischen Aggregate können feste Gele bilden, die dem Stützgewebe (extrazelluläre Matrix) Elastizität und Zugfestigkeit verleihen. In Schleimen schützen sie die Epithelien. Die erfindungsgemäße Stimulierung der Synthese von Proteoglycanen und Hyaluronsäure führt zu einer größeren Menge an extrazellulärer Matrix und damit zu einer erhöhten Elastizität und Zugfestigkeit.In the sense of the invention, dermal macromolecules are understood in principle to be all macromolecules which are found as components of the skin either in the basement membrane between Dennis and the epidermis or in the Dennis and epidermis. In particular, they are compounds selected from the group consisting of collagen, elastin, proteoglycans, fibronectins and hyaluronic acid and their salts. Collagen consists of protein fibers and occurs in human skin in three different types (Type I, ITf and IV). In collagen, the individual polypeptide chains, each with a large amount of the amino acid proline and as every third residue glycine, are wound around each other to form a triple helix. The collagen fibers are synthesized as tropocol saws in the fibroblasts and discharged into the extracellular matrix. The stimulation of the synthesis of collagen according to the invention leads to an increase in the production of collagen and thus to an increased intermolecular solidification of the Dennis and thus to a skin which appears firmer. The elastin is also a fibrous protein. These are unstructured covalently cross-linked polypeptide chains that form a rubber-like elastic material. After synthesis, the elastin is released into the extracellular matrix in the skin cells. The stimulation according to the invention of the synthesis of the elastin polypeptide chains leads to an increase in the production of elastin and thus to an increase in the elasticity of the skin. Like glycoproteins, proteoglycans consist of carbohydrates and proteins, but the proportion of polysaccharides predominates in proteoglycans. The skin's proteoglycans contain dermatan sulfate. Approx. 140 such proteoglycans with the help of smaller proteins (link proteins) accumulate non-covalently on a hyaluronic acid chain to form molecular aggregates with an average molecular weight of approx. 2 million. The polyanionic aggregates, which are characterized by their water-binding capacity, can form solid gels that give the supporting tissue (extracellular matrix) elasticity and tensile strength. They protect the epithelia in mucus. The stimulation of the synthesis of proteoglycans and hyaluronic acid according to the invention leads to a larger amount of extracellular matrix and thus to an increased elasticity and tensile strength.

Fibronectin stellt eine Gruppe hochmolekularer Glykoproteine (MR des Dimers ca. 440000- 550000) dar, die sich in der extrazellulären Matrix und in extrazellulären Flüssigkeiten finden. Das durch zwei Disulfid-Brücken verbundene Fibronectin-Dimer, ein langgestrecktes Molekül mit den Abmessungen 600x25 Ä, bindet durch lineare Kombination dreier verschiedener sich wiederholender Domänen u. a. Collagene, Glykosaminoglykane, Proteoglykane, Fibrin(ogen), Desoxyribonucleinsäuren, Immunglobuline, Plasminogen, Plasminogen- Aktivator, Thrombospondin, Zellen und Mikroorganismen. Durch diese Eigenschaften vermittelt es z. B. die Anhaftung von Bindegewebszellen an Collagen-Fibrillen oder von Thrombo- cyten und Fibroblasten an Fibrin (Beitrag zur Wundheilung).Fibronectin is a group of high-molecular glycoproteins (MR of the dimer approx. 440000-550000) that are found in the extracellular matrix and in extracellular fluids. The fibronectin dimer, connected by two disulfide bridges, an elongated molecule with the dimensions 600x25 Å, binds by linear combination of three different repeating domains and the like. a. Collagens, glycosaminoglycans, proteoglycans, fibrin (above), deoxyribonucleic acids, immunoglobulins, plasminogen, plasminogen activator, thrombospondin, cells and microorganisms. Through these properties, it conveys z. B. the adherence of connective tissue cells to collagen fibrils or of thrombocytes and fibroblasts to fibrin (contribution to wound healing).

Die Hyaluronsäure ist ein saures Glykosaminoglykan, Grundbaustein der Hyaluronsäure ist ein aus D-Glucuronsäure und N-Acetyl-D-glucosamin in (beta l-3)-glykosidischer Bindung aufgebautes Aminodisaccharid, das mit der nächsten Einheit (beta l-4)-glykosidisch verbunden ist.Hyaluronic acid is an acidic glycosaminoglycan, the basic building block of hyaluronic acid is an aminodisaccharide composed of D-glucuronic acid and N-acetyl-D-glucosamine in a (beta l-3) glycosidic bond, which is glycosidic with the next unit (beta l-4) connected is.

Die erfindungsgemäßen Extrakte können weiterhin in kosmetischen Mitteln zur Verminderung der Proteolyse und Glycation von Makromolekülen in der Haut verwendet werden. Bei der Proteolyse handelt es sich um einen Prozess, bei dem es zu einer Spaltung von Proteinen durch Hydrolyse der Peptid-Bindungen mittels Säuren oder Enzymen kommt. Eine andere Bezeichnung für Proteilyse ist die Proteinase Verdauung. Die erfindungsgemäße Verminderung der Proteolyse führt zu einer verminderten Spaltung der dermalen Makromoleküle, die eine Proteinstruktur aufweisen und damit zur Verhinderung der Verminderung einer Hautfes- tigung und zur Verhinderung des Abbaus einer erhöhten Elastizität. Die Glycation ist eine nichtenzymatische Reaktion von Glucose oder anderen Zuckern mit Proteinen zu Glycopro- teinen. Diese Reaktion führt zu unbeabsichtigten Veränderungen am Collagen und Elastin und damit zu Veränderungen der extrazellulären Matrix. Die Funktion des Collagens und der extrazellulären Matrix sind gestört. Die erfindungsgemäße Verhinderung der Glycation führt zu einer Verringerung der nichtenzymatischen Veränderung an Collagen und Elastin und damit zur Verhinderung einer verminderten Funktion der extrazellulären Matrix. Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten von Myconhiza- Pilzen in kosmetischen Mitteln als Wirkstoff mit lipolytischer Aktivität, vorzugsweise zum Einsatz gegen Cellulitis.The extracts according to the invention can furthermore be used in cosmetic compositions for reducing the proteolysis and glycation of macromolecules in the skin. Proteolysis is a process in which proteins are cleaved by hydrolysis of the peptide bonds using acids or enzymes. Another name for proteilysis is proteinase digestion. The reduction in proteolysis according to the invention leads to a reduced cleavage of the dermal macromolecules which have a protein structure and thus to prevent the reduction in skin firming and to prevent the degradation of increased elasticity. Glycation is a non-enzymatic reaction of glucose or other sugars with proteins to form glycoproteins. This reaction leads to unintentional changes to the collagen and elastin and thus to changes in the extracellular matrix. The function of the collagen and the extracellular matrix are disturbed. The prevention of glycation according to the invention leads to a reduction in the non-enzymatic change in collagen and elastin and thus to a reduction in the function of the extracellular matrix. Another object of the invention is the use of extracts of Myconhiza mushrooms in cosmetic compositions as an active ingredient with lipolytic activity, preferably for use against cellulite.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten von Myconhiza- Pilzen in kosmetischen Mitteln zur Verbesserung der Wundheilung. Als Verbesserung der Wundheilung im Sinne der Erfindung sind solche Verbesserungen zu verstehen, die bei einer krankhaften Veränderung der Haut den natürlichen Heilungsprozess unterstützen, stimulieren und verstärken können. Dabei kann eine krankhafte Veränderung der Haut unterschiedlichste Ursachen haben, eine mögliche Ursache ist eine Verletzung.Another object of the invention is the use of extracts of Myconhiza mushrooms in cosmetic products to improve wound healing. Improvements in wound healing in the sense of the invention are to be understood as improvements which can support, stimulate and intensify the natural healing process in the event of a pathological change in the skin. A pathological change in the skin can have various causes, one possible cause is an injury.

Ein weiterer Gegenstand der Erfindung ist die Verwendung von Extrakten von Myconhiza- Pilzen in kosmetischen Mitteln mit anti-alpha-5-Reductase Aktivität, vorzugsweise eine anti- Akne Aktivität und/oder eine anti-Sebonhea Aktivität für Haut und/oder Haare.Another object of the invention is the use of extracts of Myconhiza mushrooms in cosmetic products with anti-alpha-5-reductase activity, preferably an anti-acne activity and / or an anti-Sebonhea activity for skin and / or hair.

Die erfindungsgemäßen Extrakte können weiterhin in kosmetischen Mitteln gegen Alopecia eingesetzt werden. Durch die regenerierenden Eigenschaften des erfindungsgemäßen Extraktes wird auch die Kopfhaut angeregt und führt dadurch zu einer positiven Wirkung gegen A- lopecia, einem krankhaft bedingtem Haarausfall.The extracts according to the invention can also be used in cosmetic agents against alopecia. The regenerating properties of the extract according to the invention also stimulate the scalp and thereby lead to a positive effect against alopecia, a pathologically caused hair loss.

Die erfindungsgemäßen Extrakte können weiterhin in kosmetischen Mitteln als Tyrosinasein- hibitoren und/oder als Hautweißungsmittel verwendet werden. Die auch als Skin-whitener bezeichneten Hautweißungsmittel führen zu einem helleren Aussehen der Haut. Eine Möglichkeit zur Hautaufhellung oder Hautweissung führt über die lfihibierung der Tyrosinase, denn die Tyrosinase ist an der Bildung des Hautpigments Melanin beteiligt (Depigmentie- rung). Der erfindunsgemäße Einsatz von Extrakten aus Myconhiza-Pilzen führt auf Grund der Inhibierung der Tyrosinase zu einer verminderten Bildung von Melanin und damit zu einer Hautweißung. Die Extrakte aus Myconhiza-Pilzen können zusätzlich in Kombination mit weiteren Tyrosinaseinhibitoren als Depigmetierungsmittell wie beispielsweise Arbutin, Fefu- lasäure, Kojisäure, Cumarinsäure und Ascorbinsäure (Vitamin C) eingesetzt werden. Mycorrhiza-PilzeThe extracts according to the invention can furthermore be used in cosmetic compositions as tyrosine inhibitors and / or as skin whitening agents. The skin whitening agents, also known as skin whiteners, lead to a lighter skin appearance. One possibility for skin lightening or whitening is through the inhibition of tyrosinase, because tyrosinase is involved in the formation of the skin pigment melanin (depigmentation). The use of extracts from Myconhiza mushrooms according to the invention leads to a reduced formation of melanin and thus to skin whitening due to the inhibition of tyrosinase. The extracts from Myconhiza mushrooms can additionally be used in combination with other tyrosinase inhibitors as depigmenting agents such as arbutin, fefulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C). Mycorrhizal fungi

Die zur Exfraktion eingesetzten Myconhiza-Pilze werden bevorzugt aus Pilzen der Gattung Laccaria und/oder Glomus genommen. Besonders geeignet sind Pilze, die ausgewählt sind aus der Gruppe, die gebildet wird von Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescen, Thelephora terrestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricho- loma albobruneum, Hebeloma cylindrosporum, Hebeloma crusuliniforme und Glomus mos- seae.The Myconhiza mushrooms used for the extraction are preferably taken from mushrooms of the genus Laccaria and / or Glomus. Fungi which are selected from the group formed by Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescen, Thelephora terrestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporumor, and leveroma cromoma are particularly suitable - seae.

Gewinnung des Extraktes von Mycorrhiza-PilzenExtract of mycorrhizal mushrooms

Extraktionextraction

Die Herstellung der erfindungsgemäß einzusetzenden Extrakte erfolgt durch übliche Methoden der Extraktion. Bezüglich der geeigneten herkömmlichen Extraktionsverfahren wie der Mazeration, der Remazeration, der Digestion, der Bewegungsmazeration, der Wirbelextraktion, Ultraschallextraktion, der Gegenstromextraktion, der Perkolation, der Reperkolation, der Evakolation (Extraktion unter vermindertem Druck), der Diakolation und Festflüssig- Extraktion unter kontinuierlichem Rückfluß, die in einem Soxhlet-Extraktor durchgeführt wird, die dem Fachmann geläufig und im Prinzip alle anwendbar sind, sei beispielhaft auf Hagers Handbuch der Pharmazeutischen Praxis, (5. Auflage, Bd. 2, S. 1026-1030, Springer Verlag, Berlin-Heidelberg-New-York 1991) verwiesen. Als Ausgangsmaterial können frische oder getrocknete Pilze oder Pilzbestandteile eingesetzt werden, bevorzugt ist der Einsatz von getrockneten Pilzen oder Pilzbestandteilen, üblicherweise wird jedoch von Pilzen oder Pilzbestandteilen ausgegangen, die vor der Extraktion mechanisch zerkleinert werden. Hierbei eignen sich alle dem Fachmann bekannten Zerkleinerungsmethoden, als Beispiel sei die Zerstoßung mit einem Mörser genannt.The extracts to be used according to the invention are produced by customary extraction methods. Regarding the suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux , which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, is exemplary of Hager's Handbook of Pharmaceutical Practice, (5th Edition, Vol. 2, pp. 1026-1030, Springer Verlag, Berlin- Heidelberg-New-York 1991). Fresh or dried mushrooms or mushroom components can be used as the starting material, the use of dried mushrooms or mushroom components is preferred, but usually mushrooms or mushroom components are used which are mechanically comminuted before extraction. All the grinding methods known to the person skilled in the art are suitable here, for example crushing with a mortar.

Als Lösungsmittel für die Durchführung der Extraktionen können vorzugsweise Wasser, organische Lösungsmittel oder Gemische aus organischen Lösungsmitteln und Wasser, insbesondere niedrigmolekulare Alkohole, Kohlenwasserstoffe, Ketone, Ester oder halogenhaltige Kohlenwasserstoffe mit mehr oder weniger hohen Wassergehalten (destilliert oder nicht destilliert) vorzugsweise wässrig, alkoholische Lösungen einer Temperatur von größer oder gleich 20 °C verwendet werden. Besonders bevorzugt ist die Extraktion mit Wasser, Methanol, Ethanol, Hexan, Cyclohexan, Pentan, Aceton, Propylenglycolen, Polyethylenglycolen, Ethylacetat, Dichlormethan, Trichlormethan sowie Mischungen hieraus. Die Extraktion erfolgt in der Regel bei 20 bis 100 °C, bevorzugt bei 20 bis 85°C, insbesondere entweder bei Siedetemperatur des verwendeten Lösungsmittels oder bei Raumtemperatur. In einer mögli- chen Ausführungsform erfolgt die Extraktion unter Inertgasatmosphäre zur Vermeidung der Oxidation der Inhaltsstoffe des Extraktes. Die Extraktionszeiten werden vom Fachmann in Abhängigkeit vom Ausgangsmaterial, dem Extraktionsverfahren, der Extraktionstemperatur, vom Verhältnis Lösungsmittel zu Rohstoff u.a. eingestellt. Nach der Extraktion können die erhaltenen Rohexfrakte gegebenenfalls weiteren üblichen Schritten, wie beispielsweise Aufreinigung, Konzentration und/oder Entfärbung unterzogen werden. Falls wünschenswert, können die so hergestellten Extrakte beispielsweise einer selektiven Abtrennung einzelner unerwünschter Inhaltsstoffe, unterzogen werden. Die Exfraktion kann bis zu jedem gewünschten Extraktionsgrad erfolgen, wird aber gewöhnlich bis zur Erschöpfung durchgeführt. Typische Ausbeuten (= Trockensubstanzmenge des Extraktes bezogen auf eingesetzte Rohstoffmenge) bei der Exfraktion getrockneter Pilze oder getrockneter Pilzbestandteile gegebenenfalls entfettet, liegen im Bereich von 1,5 bis 25, insbesondere 1,9 bis 20,3 Gew.-%. Die vorliegende Erfindung umfasst die Erkenntnis, dass die Extraktionsbedingungen sowie die Ausbeuten der Endextrakte je nach gewünschtem Einsatzgebiet gewählt werden können. Falls gewünscht, können die Extrakte anschließend beispielsweise einer Sprüh- oder Gefriertrocknung unterworfen werden.Water, organic solvents or mixtures of organic solvents and water, in particular low-molecular alcohols, hydrocarbons, ketones, esters or halogen-containing hydrocarbons with more or less high water contents (distilled or not distilled), preferably aqueous, alcoholic solutions, can preferably be used as solvents for carrying out the extractions a temperature of greater than or equal to 20 ° C can be used. Extraction with water, methanol, ethanol, hexane, cyclohexane, pentane, acetone, propylene glycols, polyethylene glycols, ethyl acetate, dichloromethane, trichloromethane and mixtures thereof is particularly preferred. The extraction is usually carried out at 20 to 100 ° C, preferably at 20 to 85 ° C, in particular either at the boiling point of the solvent used or at room temperature. In a possible Chen embodiment, the extraction takes place under an inert gas atmosphere to avoid oxidation of the ingredients of the extract. The extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc. After the extraction, the crude fractions obtained can optionally be subjected to further conventional steps, such as purification, concentration and / or decolorization. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients. The extraction can be carried out to any desired degree of extraction, but is usually carried out until exhaustion. Typical yields (= amount of dry matter of the extract based on the amount of raw material used) in the extraction of dried mushrooms or dried mushroom components, if appropriate degreased, are in the range from 1.5 to 25, in particular 1.9 to 20.3,% by weight. The present invention includes the knowledge that the extraction conditions and the yields of the final extracts can be selected depending on the desired field of use. If desired, the extracts can then be subjected to spray or freeze drying, for example.

Die Einsatzmenge der Pilzextrakte in den genannten Zubereitungen richtet sich nach der Art der Anwendungen der Extrakte und nach der Konzentration der einzelnen Inhaltstoffe. Die Gesamtmenge des Pilzexfraktes, der in den erfindungsgemäßen Zubereitungen enthalten ist, beträgt in der Regel 0,001 bis 30 Gew.-%, vorzugsweise 0,05 bis 5 Gew.-%, insbesondere 0,03 bis 1 Gew.-% bezogen auf die Endzubereitung, mit der Maßgabe, dass sich die Mengenangaben mit Wasser und gegebenenfalls weiteren Hilfs- und Zusatzstoffen zu 100 Gew.-% addieren.The amount of mushroom extracts used in the preparations mentioned depends on the type of application of the extracts and on the concentration of the individual ingredients. The total amount of the mushroom extract contained in the preparations according to the invention is generally 0.001 to 30% by weight, preferably 0.05 to 5% by weight, in particular 0.03 to 1% by weight, based on the final preparation , with the proviso that the amounts given with water and possibly other auxiliaries and additives add up to 100% by weight.

Die Extrakte nach der Erfindung können auch in jeden anderen zutreffenden kosmetischen Vektor eingearbeitet werden oder mit ihm verbunden werden, zum Beispiel filmbildende Mittel, Liposome, Micro- und Nanokapseln, Micro- und Nanopartikel.The extracts according to the invention can also be incorporated into or connected to any other applicable cosmetic vector, for example film-forming agents, liposomes, micro and nanocapsules, micro and nanoparticles.

Ein weiterer Gegenstand der Erfindung sind demnach kosmetische Mittel enthaltend einen Extrakt aus Myccorhiza-Pilzen in verkapselter Form oder an einen Träger absorbiert.The invention accordingly furthermore relates to cosmetic compositions comprising an extract from Myccorhiza mushrooms in encapsulated form or absorbed on a carrier.

Die Begriffe Pflegemittel, Zubereitungen, Endzubereitungen und Mittel sind im Sinne der Erfindung mit dem Begriff kosmetische Mittel gleichzusetzen. Kosmetische MittelThe terms care products, preparations, final preparations and agents are to be equated with the term cosmetic agents in the sense of the invention. Cosmetic products

Als kosmetische Zubereitungen oder Mittel im Sinne der Erfindung sind Pflegemittel für die Haut zu verstehen. Diese Pflegemittel schließen unter anderem stimulierende, heilende und aufbauende Wirkung für die Haut ein. Als Pflegemittel im Sinne der Erfindung sind bevorzugt solche Pflegemittel zu verstehen, die einen stimulierenden Effekt auf die Hautzellen und deren Funktionen besitzen sowie weiterhin aufbauende Wirkung für die Haut und vorbeugende Wirkung gegen Umwelteinflüsse für die Haut zeigen. Weiterhin sind im Sinne der Erfindung bevorzugt Pflegemittel als solche zu verstehen, die verschiedene Erkrankungen der Haut mit ihren unterschiedlichen Auswirkungen auf Aussehen und Funktion der Haut entweder verbessern oder heilen können.Cosmetic preparations or agents in the sense of the invention are skin care products. These care products include stimulating, healing and building effects for the skin. Care products within the meaning of the invention are preferably those care products which have a stimulating effect on the skin cells and their functions and also have a constructive effect on the skin and preventive action against environmental influences on the skin. Furthermore, care products are preferably to be understood within the meaning of the invention as those which can either improve or cure various skin diseases with their different effects on the appearance and function of the skin.

Die erfindungsgemäßen Zubereitungen zeigen eine hervonagende hautpflegende Wirkung bei gleichzeitig hoher Hautverträglichkeit. Außerdem zeigen sie eine gute Stabilität, insbesondere gegenüber oxidativer Zersetzung der Produkte.The preparations according to the invention have an excellent skin-care effect with high skin tolerance. In addition, they show good stability, in particular against oxidative decomposition of the products.

Gewerbliche AnwendungCommercial application

Der Extrakt kann in geeignete kosmetische Vektoren, wie zum Beispiel Liposome, Makro-, Mikro und Nanokapseln, Makro-, Mikro und Nanopartikel und andere analoge und bekannte Formen ein gearbeitet werden.The extract can be worked into suitable cosmetic vectors such as liposomes, macro, micro and nanocapsules, macro, micro and nanoparticles and other analogous and known forms.

Die vorab erwähnten Extrakte können für Anwendungen zur Pflege und Hygiene der Haut verwen det werden (Erzeugnisse für Gesicht und Körper, Tag- oder Nachtkosmetika, Sonnenschutzmittel kräftigende, regenerierende Erzeugnisse, Anti-Faltenkosmetika, Schlankheitskuren-mittel, Mitte gegen Alterungsprozesse) in Form von Zubereitungen, wie zum Beispiel Lotionen oder Shampoos Cremes, Schaummittel, Seifen, Stäbchen, Gele, Hydrogele, Sprühmittel, Emulsionen, Schutzmittel reparierende, weichmachende, filmbildende und photoschützende Mittel ; Erzeugnisse für Dauerwel len und zur Haarfärbung.The aforementioned extracts can be used for skin care and hygiene applications (products for the face and body, day or night cosmetics, sunscreen strengthening, regenerating products, anti-wrinkle cosmetics, slimming products, anti-aging agents) in the form of preparations , such as lotions or shampoos, creams, foaming agents, soaps, sticks, gels, hydrogels, spray agents, emulsions, protective agents, repairing, softening, film-forming and photo-protective agents; Products for permanent waves and for coloring hair.

Die vorab erwähnten Extrakte können zur Herstellung kosmetischer Mittel, wie beispielsweise Haarshampoos, Haarlotionen, Schaumbäder, Duschbäder, Cremes, Gele, Lotionen, alkoholische und wäßrig/alkoholische Lösungen, Emulsionen, Wachs/ Fett-Massen, Stiftpräparaten, Pudern oder Salben, vornehmlich jedoch Erzeugnisse für Gesicht und Körper, Tag- oder Nachtkosmetika, Sonnenschutzmittel, kräftigende, regenerierende Erzeugnisse, Anti- Faltenkosmetika, Schlankheitskurenmittel und Mittel gegen Alterungsprozesse dienen. Diese Mittel können ferner als weitere Hilfs- und Zusatzstoffe milde Tenside, Ölkörper, Emulgato- ren, Perlglanzwachse, Konsistenzgeber, Verdickungsmittel, Überfettungsmittel, Stabilisato- ren, Polymere, Siliconverbindungen, Fette, Wachse, Lecithine, Phospholipide, biogene Wirkstoffe, UV-Lichtschutzfaktoren, Antioxidantien, Deodorantien, Antitranspirantien, Anti- schuppenmittel, Filmbildner, Quellmittel, Insektenrepellentien, Selbstbräuner, Tyrosininhibi- toren (Depigmentierungsmittel), Hydrotrope, Solubilisatoren, Konservierungsmittel, Parfümöle, Farbstoffe und dergleichen enthalten.The above-mentioned extracts can be used for the production of cosmetic agents, such as hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat masses, stick preparations, powders or ointments, but primarily products for face and body, day or night cosmetics, sunscreens, strengthening, regenerating products, anti-wrinkle cosmetics, slimming products and agents against aging processes. These agents can also be used as further auxiliaries and additives, mild surfactants, oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers. Ren, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, UV light protection factors, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, self-tanners, tyrosine inhibitors (depigmenting agents, solubilizers, hydrotrope) Contain preservatives, perfume oils, dyes and the like.

Tensidesurfactants

Als oberflächenaktive Stoffe können anionische, nichtionische, kationische und/oder amphotere bzw. amphotere Tenside enthalten sein, deren Anteil an den Mitteln üblicherweise bei etwa 1 bis 70, vorzugsweise 5 bis 50 und insbesondere 10 bis 30 Gew.-% beträgt. Typische Beispiele für anionische Tenside sind Seifen, Alkylbenzolsulfonate, Alkansulfonate, Olefin- sulfonate, Alkylethersulfonate, Glycerinethersulfonate, α-Methylestersulfonate, Sul- fofettsäuren, Alkylsulfate, Fettalkoholethersulfate, Glycerinethersulfate, Fettsäureethersulfate, Hydroxymischethersulfate, Monoglycerid(ether)sulfate, Fettsäureamid(ether)sulfate, Mono- und Dialkylsulfosuccinate, Mono- und Dialkylsulfosuccinamate, Sulfotriglyceride, Amidsei- fen, Ethercarbonsäuren und deren Salze, Fettsäureisethionate, Fettsäuresarcosinate, Fettsäure- tauride, N-Acylaminosäuren, wie beispielsweise Acyllactylate, Acyltartrate, Acylglutamate und Acylaspartate, Alkyloligoglucosidsulfate, Proteinfettsäurekondensate (insbesondere pflanzliche Produkte auf Weizenbasis) und Alkyl(ether)phosphate. Sofern die anionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für nichtionische Tenside sind Fettalkoholpolyglycolether, Alkylphenolpolyglycolether, Fettsäurepoly- glycolester, Fettsäureamidpolyglycolether, Fettaminpolyglycolether, alkoxylierte Triglyceride, Mischether bzw. Mischformale, gegebenenfalls partiell oxidierte Alk(en)yloligoglykoside bzw. Glucoronsäurederivate, Fettsäure-N-alkylglucamide, Proteinhydrolysate (insbesondere pflanzliche Produkte auf Weizenbasis), Polyolfettsäureester, Zuckerester, Sorbitanester, Poly- sorbate und Aminoxide. Sofern die nichtionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für kationische Tenside sind quartäre Ammonium- verbindungen, wie beispielsweise das Dimethyldistearylammoniumchlorid, und Esterquats, insbesondere quaternierte Fettsäuretrialkanolaminestersalze. Typische Beispiele für amphotere bzw. zwitterionische Tenside sind Alkylbetaine, Alkylamidobetaine, Aminopropionate, Ami- noglycinate, Imidazoliniumbetaine und Sulfobetaine. Bei den genannten Tensiden handelt es sich ausschließlich um bekannte Verbindungen. Typische Beispiele für besonders geeignete milde, d.h. besonders hautverträgliche Tenside sind Fettalkoholpolyglycolethersulfate, Mo- noglyceridsulfate, Mono- und/oder Dialkylsulfosuccinate, Fettsäureisethionate, Fettsäuresarcosinate, Fettsäuretauride, Fettsäureglutamate, α-Olefinsulfonate, Ethercarbonsäuren, Alkylo- ligoglucoside, Fettsäureglucamide, Alkylamidobetaine, Amphoacetale und/oder Proteinfettsäurekondensate, letztere vorzugsweise auf Basis von Weizenproteinen.Anionic, nonionic, cationic and / or amphoteric or amphoteric surfactants can be present as surface-active substances, the proportion of the agents usually being about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight. Typical examples of anionic surfactants are soaps, alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, α-methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, fatty acid ether sulfates, hydroxymate sulfate ethersulfates, hydroxymate sulfate ethersulfates, hydroxymate sulfate etherates, Mono- and dialkylsulfosuccinates, mono- and dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, N-acylamino acids, such as, for example, acyl lactylates, acyl tartarate sulfates, product acyl glucosate trate, acyl glucosate trate, acyl glucosate trate, acyl glucosate trate, acyl glucosate fate, acyl glucosate fate, acyl glucosate fate, acyl glucosate fate, acyl glucate fate based on wheat) and alkyl (ether) phosphates. If the anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution. Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or especially glucoramide acid vegetable derivatives, fatty acid glucoronic acid protein derivatives, and fatty acid glucoramides Wheat base), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides. If the nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts. Typical examples of amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazoliniumbetaines and sulfobetaines. The surfactants mentioned are exclusively known compounds. Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, α-olefin sulfonates, ether carboxylic acids ligoglucoside, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates, the latter preferably based on wheat proteins.

Ölkörperoil body

Als Ölkörper kommen beispielsweise Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 Kohlenstoffatomen, Ester von linearen C6-C22-Fettsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen bzw. Ester von verzweigten C6-Cι3- Carbonsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen, wie z.B. Myristylmyristat, Myristylpalmitat, Myristylstearat, Myristylisostearat, Myristyloleat, Myristylbehenat, Myristy- lerucat, Cetylmyristat, Cetylpalmitat, Cetylstearat, Cetylisostearat, Cetyloleat, Cetylbehenat, Cetylerucat, Stearylmyristat, Stearylpalmitat, Stearylstearat, Stearylisostearat, Stearyloleat, Stearylbehenat, Stearylerucat, Isostearylmyristat, Isostearylpalmitat, Isostearylstearat, Isostea- rylisostearat, Isostearyloleat, Isostearylbehenat, Isostearyloleat, Oleylmyristat, Oleylpalmitat, Oleylstearat, Oleylisostearat, Oleyloleat, Oleylbehenat, Oleylerucat, Behenylmyristat, Behe- nylpalmitat, Behenylstearat, Behenylisostearat, Behenyloleat, Behenylbehenat, Behenylerucat, Erucylmyristat, Erucylpahnitat, Erucylstearat, Erucylisostearat, Erucyloleat, Erucylbehenat und Erucylerucat. Daneben eignen sich Ester von linearen C6-C22-Fettsäuren mit verzweigten Alkoholen, insbesondere 2-Ethylhexanol, Ester von C18-C38-Alkylhydroxycarbonsäuren mit linearen oder verzweigten C6-C 2-Fettalkoholen, insbesondere Dioctyl Malate, Ester von linearen und/oder verzweigten Fettsäuren mit mehrwertigen Alkoholen (wie z.B. Propylenglycol, Dimerdiol oder Trirnertriol) und/oder Guerbetalkoholen, Triglyceride auf Basis Ce- o-Fett- säuren, flüssige Mono-/Di-/Triglyceridmischungen auf Basis von C6-C18-Fettsäuren, Ester von C6-C22-Fettalkoholen undoder Guerbetalkoholen mit aromatischen Carbonsäuren, insbesondere Benzoesäure, Ester von C2-C12-Dicarbonsäuren mit linearen oder verzweigten Alkoholen mit 1 bis 22 Kohlenstoffatomen oder Polyolen mit 2 bis 10 Kohlenstoffatomen und 2 bis 6 Hydroxylgruppen, pflanzliche Öle, verzweigte primäre Alkohole, substituierte Cyclohexane, lineare und verzweigte C6-C 2-Fettalkoholcarbonate5 wie z.B. Dicaprylyl Carbonate (Cetiol® CC), Guerbetcarbonate auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 C Atomen, Ester der Benzoesäure mit linearen und oder verzweigten C6-C22- Alkoholen (z.B. Finsolv® TN), lineare oder verzweigte, symmetrische oder unsymmetrische Dialkylether mit 6 bis 22 Kohlenstoffatomen pro Alkylgruppe, wie z.B. Dicaprylyl Ether (Cetiol® OE), Ring- öffhungsprodukte von epoxidierten Fettsäureestern mit Polyolen, Siliconöle (Cyclomethicone, Siliciummethicontypen u.a.) und/oder aliphatische bzw. naphthenische Kohlenwasserstoffe, wie z.B. wie Squalan, Squalen oder Dialkylcyclohexane in Betracht. EmulgatorenSuitable oil bodies are, for example, Guerbet alcohols preferably containing 8 to 10 carbon atoms, esters based on fatty alcohols having 6 to 18, of linear C6-C22 fatty acids with linear or branched C 6 -C 22 -fatty alcohols or esters of branched C 6 -Cι 3 - Carboxylic acids with linear or branched C 6 -C 22 fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, myristyl behenate, myristyl lerucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, cetyl stearate, stearyl stearate, Stearylisostearat, stearyl oleate, stearyl behenate, Stearylerucat, isostearyl, isostearyl palmitate, Isostearylstearat, Isostea- rylisostearat, Isostearyloleat, isostearyl behenate, Isostearyloleat, nylpalmitat oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, Oleylbehenat, oleyl erucate, behenyl myristate, behenyl palmitate, behenyl, Behenylisostearat, Behenylo leat, behenyl behenate, behenyl erucate, erucyl myristate, erucyl dentate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl erucate. In addition, esters of linear C 6 -C 22 fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of C 18 -C 38 alkylhydroxycarboxylic acids with linear or branched C 6 -C 2 fatty alcohols, in particular dioctyl malates, esters of linear ones and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or Trirner triol) and / or Guerbet alcohols, triglycerides based on Ce fatty acids, liquid mono- / di- / triglyceride mixtures based on C 6 -C 18 - Fatty acids, esters of C 6 -C 22 fatty alcohols and or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C 2 -C 12 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 Hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C 6 -C 2 fatty alcohol carbonates 5 such as dicaprylyl carbonates (cetiol ® CC), Guerbet carbonates based on fatty alcohols with 6 to 18, preferably 8 to 10 C atoms, esters of benzoic acid with linear and or branched C 6 -C 22 alcohols (eg Finsolv® TN), linear or branched, symmetrical or asymmetrical Dialkyl ethers with 6 to 22 carbon atoms per alkyl group, such as, for example, dicaprylyl ether (Cetiol® OE), ring-opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicon methicone types, etc.) and / or aliphatic or naphthenic hydrocarbons, such as, for example, squalane, squalene or dialkylcyclohexanes. emulsifiers

Als Emulgatoren kommen beispielsweise nichtionogene Tenside aus mindestens einer der folgenden Gruppen in Frage:Suitable emulsifiers are, for example, nonionic surfactants from at least one of the following groups:

> Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/ oder 0 bis 5 Mol Propyleno- xid an lineare Fettalkohole mit 8 bis 22 C- Atomen, an Fettsäuren mit 12 bis 22 C- Atomen, an Alkylphenole mit 8 bis 15 C- Atomen in der Alkylgruppe sowie Alkylamine mit 8 bis 22 Kohlenstoffatomen im Alkylrest; Alkyl- und/oder Alkenyloligoglykoside mit 8 bis 22 Kohlenstoffatomen im Alk(en)ylrest und deren ethoxylierte Analoga;> Adducts of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide with linear fatty alcohols with 8 to 22 C atoms, with fatty acids with 12 to 22 C atoms, with alkylphenols with 8 to 15 C atoms in the Alkyl group and alkylamines with 8 to 22 carbon atoms in the alkyl radical; Alkyl and / or alkenyl oligoglycosides with 8 to 22 carbon atoms in the alk (en) yl radical and their ethoxylated analogs;

> Anlagerungsprodukte von 1 bis 15 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 1 to 15 moles of ethylene oxide with castor oil and / or hardened castor oil;

> Anlagerungsprodukte von 15 bis 60 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 15 to 60 moles of ethylene oxide with castor oil and / or hardened castor oil;

> Partialester von Glycerin und/oder Sorbitan mit ungesättigten, linearen oder gesättigten, verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of glycerol and / or sorbitan with unsaturated, linear or saturated, branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 mol ethylene oxide;

> Partialester von Polyglycerin (durchschnittlicher Eigenkondensationsgrad 2 bis 8), Polye- thylenglycol (Molekulargewicht 400 bis 5000), Trimethylolpropan, Pentaerythrit, Zuckeralkoholen (z.B. Sorbit), Alkylglucosiden (z.B. Methylglucosid, Butylglucosid, Laurylglu- cosid) sowie Polyglucosiden (z.B. Cellulose) mit gesättigten und/oder ungesättigten, linearen oder verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (eg sorbitol), alkyl glucosides (eg methyl glucoside, butyl glucoside, lauryl glucoside) as well as polyglucosides (eg cellulose) saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;

> Mischester aus Pentaerythrit, Fettsäuren, Citronensäure und Fettalkohol und/oder> Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and / or

Mischester von Fettsäuren mit 6 bis 22 Kohlenstoffatomen, Methylglucose und Polyolen, vorzugsweise Glycerin oder Polyglycerin.Mixed esters of fatty acids with 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol.

> Mono-, Di- und Trialkylphosphate sowie Mono-, Di- und oder Tri-PEG- alkylphosphate und deren Salze;> Mono-, di- and trialkyl phosphates and mono-, di- and or tri-PEG-alkyl phosphates and their salts;

> Wollwachsalkohole;> Wool wax alcohols;

> Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;> Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives;

> Block-Copolymere z.B. Polyethylenglycol-30 Dipolyhydroxystearate; Polymeremulgatoren, z.B. Pemulen-Typen (TR-l,TR-2) von Goodrich;> Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate; Polymer emulsifiers, e.g. Pemulen types (TR-1, TR-2) from Goodrich;

> Polyalkylenglycole sowie> Polyalkylene glycols as well

> Glycerincarbonat. Ethylenoxidanlagerungsprodukte> Glycerine carbonate. Ethylene Oxide

Die Anlagerungsprodukte von Ethylenoxid und/oder von Propylenoxid an Fettalkohole, Fettsäuren, Alkylphenole oder an Ricinusöl stellen bekannte, im Handel erhältliche Produkte dar. Es handelt sich dabei um Homologengemische, deren mittlerer Alkoxy- lierungsgrad dem Verhältnis der Stoffmengen von Ethylenoxid und/ oder Propylenoxid und Substrat, mit denen die Anlagerungsreaktion durchgeführt wird, entspricht. C12/18- Fettsäuremono- und -diester von Anlagerungsprodukten von Ethylenoxid an Glycerin sind als Rückfettungsmittel für kosmetische Zubereitungen bekannt.The adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. C 12/18 - fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic preparations.

Alkyl- und/oder AlkenyloligoglykosideAlkyl and / or alkenyl oligoglycosides

Alkyl- und/oder Alkenyloligoglycoside, ihre Herstellung und ihre Verwendung sind aus dem Stand der Technik bekannt. Ihre Herstellung erfolgt insbesondere durch Umsetzung von Glucose oder Oligosacchariden mit primären Alkoholen mit 8 bis 18 Kohlenstoffatomen. Bezüglich des Glycosidrestes gilt, daß sowohl Monoglycoside, bei denen ein cyc- lischer Zuckenest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Gly- coside mit einem Oligomerisationsgrad bis vorzugsweise etwa 8 geeignet sind. Der Oli- gomerisierungsgrad ist dabei ein statistischer Mittelwert, dem eine für solche technischen Produkte übliche Homologenverteilung zugrunde liegt.Alkyl and / or alkenyl oligoglycosides, their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms. With regard to the glycoside residue, both monoglycosides in which a cyclic sugar nest is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to approximately 8 are suitable. The degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.

Partialglyceridepartial glycerides

Typische Beispiele für geeignete Partialglyceride sind Hydroxystearinsäuremonoglycerid, Hydroxystearinsäurediglycerid, Isostearinsäuremonoglycerid, Isostearinsäurediglycerid, Ölsäuremonoglycerid, Ölsäurediglycerid, Ricinolsäuremoglycerid, Ricinolsäurediglyce- rid, Linolsäuremonoglycerid, Linolsäurediglycerid, Linolensäuremonogiycerid, Linolen- säurediglycerid, Erucasäuremonoglycerid, Erucasäurediglycerid, Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglycerid, Äpfelsäuremo- noglycerid, Äpfelsäurediglycerid sowie deren technische Gemische, die untergeordnet aus dem Herstellungsprozeß noch geringe Mengen an Triglycerid enthalten können. Ebenfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol Ethylenoxid an die genannten Partialglyceride. > SorbitanesterTypical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid, Isostearinsäurediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolsäuremoglycerid, Ricinolsäurediglyce- chloride, Linolsäuremonoglycerid, Linolsäurediglycerid, Linolensäuremonogiycerid, linolenic säurediglycerid, Erucasäuremonoglycerid, Erucasäurediglycerid, Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglycerid, Äpfelsäuremo- noglycerid, Malic acid diglyceride and their technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the partial glycerides mentioned are also suitable. > Sorbitan esters

Als Sorbitanester kommen Sorbitanmonoisostearat, Sorbitansesquiisostearat, Sorbitan- diisostearat, Sorbitantriisostearat, Sorbitanmonooleat, Sorbitansesquioleat, Sorbitan- dioleat, Sorbitantrioleat, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, Sorbi- tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat, Sorbitansesqui- tartrat, Sorbitanditartrat, Sorbitantritarfrat, Sorbitanmonocitrat, Sorbitansesquicitrat, Sor- bitandicitrat, Sorbitantricitrat, Sorbitanmonomaleat, Sorbitansesquimaleat, Sorbitan- dimaleat, Sorbitantrimaleat sowie deren technische Gemische. Ebenfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol Ethylenoxid an die genannten Sorbitanester.As sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan come diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan dioleate, trioleate, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, sorbitan tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitan sesquitarate, sorbitan ditartrate, sorbitan tritarate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan citrate, sorbitan tricitrate, sorbitan monomaleate, sorbitan sesquimaleate, sorbitan dimaleate, sorbitan trimaleate and their technical mixtures. Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the sorbitan esters mentioned are also suitable.

> Polyglycerinester> Polyglycerol esters

Typische Beispiele für geeignete Polyglycerinester sind Polyglyceryl-2 Dipolyhydro- xystearate (Dehymuls® PGPH), Polyglycerin-3-Diisostearate (Lameform® TGI), Po- lyglyceryl-4 Isostearate (Isolan® GI 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyce- ryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) und Polyglyceryl Polyricinoleate (Admul® WOL 1403) Po- lyglyceryl Dimerate Isostearate sowie deren Gemische. Beispiele für weitere geeignete Polyolester sind die gegebenenfalls mit 1 bis 30 Mol Ethylenoxid umgesetzten Mono-, Di- und Triester von Trimethylolpropan oder Pentaerythrit mit Laurinsäure, Kokosfettsäure, Taigfettsäure, Palmitinsäure, Stearinsäure, Ölsäure, Behensäure und dergleichen.Typical examples of suitable polyglycerol esters are polyglyceryl-2 dipolyhydroxystearate (Dehymuls® PGPH), polyglycerol-3-diisostearate (Lameform® TGI), polyglyceryl-4 isostearate (Isolan® GI 34), polyglyceryl-3 oleates, diisostearoyl polyglyce ryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether ( Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Isostearate and their mixtures. Examples of other suitable polyol esters are the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.

Anionische EmulgatorenAnionic emulsifiers

Typische anionische Emulgatoren sind aliphatische Fettsäuren mit 12 bis 22 Kohlenstoff- atomen, wie beispielsweise Palmitinsäure, Stearinsäure oder Behensäure, sowie Dicar- bonsäuren mit 12 bis 22 Kohlenstoffatomen, wie beispielsweise Azelainsäure oder Seba- cinsäure. > Amphothere und kationische EmulgatorenTypical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid. > Amphoteric and cationic emulsifiers

Weiterhin können als Emulgatoren zwitterionische Tenside verwendet werden. Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine Carboxylat- und eine Sulfonatgruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-AJJcyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acylaminopropyl-N,N- dimethylammonium-glycinate, beispielsweise das Kokosacylammopropyldimethyl- ammoniumglycinat, und 2-Alkyl-3-carboxylmethyl-3-hydroxyethylimidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethyl- hydroxyethylcarboxymethylglycinat. Besonders bevorzugt ist das unter der CTFA- Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat. Ebenfalls geeignete Emulgatoren sind ampholytische Tenside. Unter ampholytischen Tensiden werden solche oberflächenaktiven Verbindungen verstanden, die außer einer C8/18-Alkyl- oder Acylgruppe im Molekül mindestens eine freie Aminogruppe und mindestens eine - COOH- oder -SO3H-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylpropion- säuren, N-Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren, N-Hydroxyethyl-N- alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 18 C-Atomen in der Alkylgruppe.. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropionat und das C12/18-Acylsarcosin. Schließlich kommen auch Kationtenside als Emulgatoren in Betracht, wobei solche vom Typ der Esterquats, vorzugsweise methylquaternierte Difettsäuretriethanolaminester-Salze, besonders bevorzugt sind.Zwitterionic surfactants can also be used as emulsifiers. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-AJJcyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylammopropyldimethylammoniumglycinate, and 2-alkylmethyl-carboxylate -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the coconut acylaminoethyl hydroxyethyl carboxymethyl glycinate. The fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine is particularly preferred. Suitable emulsifiers are ampholytic surfactants. Ampholytic surfactants are surface-active compounds which, in addition to a C 8/18 alkyl or acyl group, contain at least one free amino group and at least one - COOH or -SO 3 H group in the molecule and are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group .. particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 12/18 acyl sarcosine. Finally, cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.

Fette und WachseFats and waxes

Typische Beispiele für Fette sind Glyceride, d.h. feste oder flüssige pflanzliche oder tierische Produkte, die im wesentlichen aus gemischten Glycerinestern höherer Fettsäuren bestehen, als Wachse kommen u.a. natürliche Wachse, wie z.B. Candelillawachs, Carnaubawachs, Japanwachs, Espartograswachs, Korkwachs, Guarumawachs, Reiskeimölwachs, Zuckenohrwachs, Ouricurywachs, Montanwachs, Bienenwachs, Schellackwachs, Walrat, Lanolin (Wollwachs), Bürzelfett, Ceresin, Ozokerit (Erdwachs), Petrolatum, Paraffinwachse, Mikrowachse; chemisch modifizierte Wachse (Hartwachse), wie z.B. Montanesterwachse, Sasolwachse, hydrierte Jojobawachse sowie synthetische Wachse, wie z.B. Polyalkylenwachse und Polyethylengly- colwachse in Frage. Neben den Fetten kommen als Zusatzstoffe auch fettähnliche Substanzen, wie Lecithine und Phospholipide in Frage. Unter der Bezeichnung Lecithine versteht der Fachmann diejenigen Glycero-Phospholipide, die sich aus Fettsäuren, Glycerin, Phosphorsäure und Cholin durch Veresterung bilden. Lecithine werden in der Fachwelt daher auch häufig als Phosphatidylcholine (PC). Als Beispiele für natürliche Lecithine seien die Kephaline genannt, die auch als Phosphatidsäuren bezeichnet werden und Derivate der 1,2-Diacyl-sn- glycerin-3-phosphorsäuren darstellen. Dem gegenüber versteht man unter Phospholipiden gewöhnlich Mono- und vorzugsweise Diester der Phosphorsäure mit Glycerin (Glycerinphos- phate), die allgemein zu den Fetten gerechnet werden. Daneben kommen auch Sphingosine bzw. Sphingolipide in Frage.Typical examples of fats are glycerides, that is to say solid or liquid vegetable or animal products which essentially consist of mixed glycerol esters of higher fatty acids, and waxes include natural waxes, such as candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax and sugar ear wax , Ouricury wax, montan wax, beeswax, shellac wax, walrus, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, micro waxes; chemically modified waxes (hard waxes), such as montan ester waxes, sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as polyalkylene waxes and polyethylene glycol colwaxes in question. In addition to fats, fat-like substances such as lecithins and phospholipids can also be used as additives. The person skilled in the art understands the term lecithins as those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC). Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids. In contrast, phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats. In addition, sphingosines or sphingolipids are also suitable.

Perlglanzwachsepearlescent

Als Perlglanzwachse kommen beispielsweise in Frage: Alkylenglycolester, speziell Ethy- lenglycoldistearat; Fettsäurealkanolamide, speziell Kokosfettsäurediethanolamid; Partialglyceride, speziell Stearinsäuremonoglycerid; Ester von mehrwertigen, gegebenenfalls hydroxy- substituierte Carbonsäuren mit Fettalkoholen mit 6 bis 22 Kohlenstoffatomen, speziell lang- kettige Ester der Weinsäure; Fettstoffe, wie beispielsweise Fettalkohole, Fettketone, Fettaldehyde, Fettether und Fettcarbonate, die in Summe mindestens 24 Kohlenstoffatome aufweisen, speziell Lauron und Distearylether; Fettsäuren wie Stearinsäure, Hydroxystearinsäure oder Behensäure, Ringöffhungsprodukte von Olefmepoxiden mit 12 bis 22 Kohlenstoffatomen mit Fettalkoholen mit 12 bis 22 Kohlenstoffatomen und/oder Polyolen mit 2 bis 15 Kohlenstoffatomen und 2 bis 10 Hydroxylgruppen sowie deren Mischungen.Pearlescent waxes that can be used are, for example: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.

Konsistenzgeber und VerdickungsmittelConsistency agents and thickeners

Als Konsistenzgeber kommen in erster Linie Fettalkohole oder Hydroxyfettalkohole mit 12 bis 22 und vorzugsweise 16 bis 18 Kohlenstoffatomen und daneben Partialglyceride, Fettsäuren oder Hydroxyfettsäuren in Betracht. Bevorzugt ist eine Kombination dieser Stoffe mit Alkyloligoglucosiden und/oder Fettsäure-N-methylglucamiden gleicher Kettenlänge und/oder Polyglycerinpoly-12-hydroxystearaten. Geeignete Verdickungsmittel sind beispielsweise Ae- rosil-Typen (hydrophile Kieselsäuren), Polysaccharide, insbesondere Xanthan-Gum, Guar- Guar, Agar-Agar, Alginate und Tylosen, Carboxymethylcellulose und Hydroxyethyl- und Hydroxypropylcellulose, ferner höhermolekulare Polyethylenglycolmono- und -diester von Fettsäuren, Polyacrylate, (z.B. Carbopole® und Pemulen-Typen von Goodrich; Synthalene® von Sigma; Keltrol-Typen von Kelco; Sepigel-Typen von Seppic; Salcare-Typen von Allied Colloids), Polyacrylamide, Polymere, Polyvinylalkohol und Polyvinylpyrrolidon. Als beson- ders wirkungsvoll haben sich auch Bentonite, wie z.B. Bentone® Gel VS-5PC (Rheox) erwiesen, bei dem es sich um eine Mischung aus Cyclopentasiloxan, Disteardimonium Hectorit und Propylencarbonat handelt. Weiter in Frage kommen Tenside, wie beispielsweise ethoxylierte Fettsäureglyceride, Ester von Fettsäuren mit Polyolen wie beispielsweise Pentaerythrit oder Trimethylolpropan, Fettalkoholethoxylate mit eingeengter Homologenverteilung oder Alkylo- ligoglucoside sowie Elektrolyte wie Kochsalz und Ammoniumchlorid.Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred. Suitable thickeners are, for example, aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, Polyacrylates (e.g. Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinylpyrrolidone. As a special Bentonites such as Bentone® Gel VS-5PC (Rheox), which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate, have also proven to be effective. Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.

Überfettungsmittelsuperfatting

Als Überfettungsmittel können Substanzen wie beispielsweise Lanolin und Lecithin sowie polyethoxylierte oder acylierte Lanolin- und Lecithinderivate, Polyolfettsäureester, Monogly- ceride und Fettsäurealkanolamide verwendet werden, wobei die letzteren gleichzeitig als Schaumstabilisatoren dienen.Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.

Stabilisatorenstabilizers

Als Stabilisatoren können Metallsalze von Fettsäuren, wie z.B. Magnesium-, Aluminium- und/oder Zinkstearat bzw. -ricinoleat eingesetzt werden.Metal salts of fatty acids, such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.

Polymerepolymers

Geeignete kationische Polymere sind beispielsweise kationische Cellulosederivate, wie z.B. eine quaternierte Hydroxyethylcellulose, die unter der Bezeichnung Polymer JR 400® von Amerchol erhältlich ist, kationische Stärke, Copolymere von Diallylammoniumsalzen und Acrylamiden, quaternierte Vinylpynolidon Vinylimidazol-Polymere, wie z.B. Luviquat® (BASF), Kondensationsprodukte von Polyglycolen und Aminen, quaternierte Kollagenpoly- peptide, wie beispielsweise Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lame- quat®L/Grünau), quaternierte Weizenpolypeptide, Polyethylenimin, kationische Siliconpolymere, wie z.B. Amodimethicone, Copolymere der Adipinsäure und Dimethyla- minohydroxypropyldiethylentriamin (Cartaretine®/Sandoz), Copolymere der Acrylsäure mit Dimethyl-diallylammoniumchlorid (Merquat® 550/Chemviron), Polyaminopolyamide, sowie deren vernetzte wasserlöslichen Polymere, kationische Chitinderivate wie beispielsweise qua- terniertes Chitosan, gegebenenfalls mikrokristallin verteilt, Kondensationsprodukte aus Diha- logenalkylen, wie z.B. Dibrombutan mit Bisdialkylaminen, wie z.B. Bis-Dimethylamino-1,3- propan, kationischer Guar-Gum, wie z.B. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 der Firma Celanese, quaternierte Ammoniumsalz-Polymere, wie z.B. Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 der Firma Miranol. Als anionische, zwitterionische, amphotere und nichtionische Polymere kommen beispielsweise Vinylacetat/Crotonsäure-Copolymere, Vinylpynolidon/Vinylacrylat-Copolymere, Vi- nylacetat/Butylmaleat/ Isobornylacrylat-Copolymere, Methylvinylether Malemsäureanhydrid- Copolymere und deren Ester, unvernetzte und mit Polyolen vernetzte Polyacrylsäuren, Acryl- amidopropyltrimethylammomumchlorid/ Acrylat-Copolymere, Octylacrylamid/Methylmeth- acιylat/tert.Butylaminoemylmethacrylat/2-Hycfroxypropylmethacrylat-Copolymere, Polyvi- nylpynolidon, Vinylpynolidon/Vinylacetat-Copolymere, Vinylpynolidon/ Dimethylamino- ethylmethacrylat/Vinylcaprolactam-Terpolymere sowie gegebenenfalls derivatisierte Cellulo- seether und Silicone in Frage.Suitable cationic polymers are, for example, cationic cellulose derivatives, such as a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpynolidone vinylimidazole polymers, such as Luviquat® (BASF), Condensation products of polyglycols and amines, quaternized collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as amodimethicones, copolymers of adipic acid and dimethyldiethylroxin (hydroxymethylaminohydroxin) -dimethylaminohydroxin Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides, and their crosslinked water-soluble polymers, cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline distributed, condensation products from dihaloalkylene, such as dibromobutane with bisdialkylamines, such as bis-dimethylamino-1,3-propane, cationic guar gum, such as Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from the company Celanese, quaternized ammonium salt polymers, such as Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol. Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpynolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornylacrylate copolymers, methyl vinyl ether, maleic anhydride copolymers and their esters, crosslinked acrylics and their polyols, non-crosslinked acrylic and amidopropyltrimethylammomum chloride / acrylate copolymers, octylacrylamide / methyl methacrylicate / tert-butylaminoemyl methacrylate / 2-hyroxroxypropyl methacrylate copolymers, polyvinylpynolidone, vinylpynolidone / vinyl acetate copolymers, vinylpynolidone / vinyl acrylate and vinyl acrylate / vinyl acrylate / methylethyl derivatized vinyl methacrylate / dimethylamino-polyol derivative / dimethylamino-cellulose-in-copolymer Question.

Siliconverbindungensilicone compounds

Geeignete Siliconverbindungen sind beispielsweise Dimethylpolysiloxane, Methylphenylpo- lysiloxane, cyclische Silicone sowie amino-, fettsäure-, alkohol-, polyether-, epoxy-, fluor-, glykosid- und/oder alkylmodifizierte Siliconverbindungen, die bei Raumtemperatur sowohl flüssig als auch harzförmig vorliegen können. Weiterhin geeignet sind Simethicone, bei denen es sich um Mischungen aus Dimethiconen mit einer durchschnittlichen Kettenlänge von 200 bis 300 Dimethylsiloxan-Einheiten und hydrierten Silicaten handelt.Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds which can be both liquid and resinous at room temperature. Simethicones, which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.

Antioxidantienantioxidants

Neben den beiden vorgenannten Gruppen primärer Lichtschutzstoffe können auch sekundäre Lichtschutzmittel vom Typ der Antioxidantien eingesetzt werden, die die photochemische Reaktionskette unterbrechen, welche ausgelöst wird, wenn UV-Strahlung in die Haut eindringt. Typische Beispiele taerfür sind Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryp- tophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Carnosin, D-Carnosin, L-Carnosin und deren Derivate (z.B. Anserin), Carotinoide, Caroline (z.B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure), Aurothioglucose, Propylthi- ouracil und andere Thiole (z.B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionät, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipi- de, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfo- ximine, Homocysteinsulfoximin, Butioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen (z.B. pmol bis μmol/kg), ferner (Metall)-Chelatoren (z.B. α-Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lactoferrin), -Hydroxysäuren (z.B. Citronensäure, Milchsäure, Äpfelsäure), Huminsäure, Gallensäure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z.B. γ-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und Ubi- chinol und deren Derivate, Vitamin C und Derivate (z.B. Ascorbylpalmitat, Mg-Ascor- bylphosphat, Ascorbylacetat), Tocopherole und Derivate (z.B. Vitamin-E-acetat), Vitamin A und Derivate (Vitamin- A-palmitat) sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, α-Glycosylrutin, Ferulasäure, Furfurylidenglucitol, Carnosin, Butylhydroxy- toluol, Butylhydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydro- xybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Superoxid- Dismutase, Zink und dessen Derivate (z.B. ZnO, ZnSO4) Selen und dessen Derivate (z.B. Se- len-Methionin), Stilbene und deren Derivate (z.B. Stilbenoxid, trans-Stilbenoxid) und die erfindungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser genannten Wirkstoffe.In addition to the two aforementioned groups of primary light stabilizers, it is also possible to use secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin. Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. Anserine), carotenoids, caroline (e.g. α-carotene, ß-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, Cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, penta-, hexa-, himinath) in very low tolerable doses (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, biliary extracts, bilirubin , Biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg- Ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, α-glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine Butylhydroxy toluene, butylated hydroxyanisole, nordihydroguajakharzäure, Nordihydroguajaretsäure, trihydroxybutyrophenon, uric acid and its derivatives, mannose and its derivatives, superoxide D ismutase, zinc and its derivatives (eg ZnO, ZnSO 4 ) selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, Sugar, nucleotides, nucleosides, peptides and lipids) of these active ingredients.

Bio ene WirkstoffeBio active ingredients

Unter biogenen Wirkstoffen sind beispielsweise Tocopherol, Tocopherolacetat, Tocopherol- palmitat, Ascorbinsäure, (Desoxy)Ribonucleinsäure und deren Fragmentierungsprodukte, ß- Glucane, Retinol, Bisabolol, Allantoin, Phytantriol, Panthenol, AHA-Säuren, Aminosäuren, Ceramide, Pseudoceramide, essentielle Öle, Pflanzenextrakte und Vitaminkomplexe zu verstehen.Examples of biogenic active substances include tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, β-glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudo-ceramides, essentielle ceramides, To understand plant extracts and vitamin complexes.

Deodorantien und keimhemmende MittelDeodorants and germ inhibitors

Kosmetische Deodorantien (Desodorantien) wirken Körpergerüchen entgegen, überdecken oder beseitigen sie. Körpergerüche entstehen durch die Einwirkung von Hautbakterien auf apokrinen Schweiß, wobei unangenehm riechende Abbauprodukte gebildet werden. Dementsprechend enthalten Deodorantien Wirkstoffe, die als keimhemmende Mittel, Enzyminhibito- ren, Geruchsabsorber oder Geruchsüberdecker fungieren. Keimhemmende MittelCosmetic deodorants counteract, mask or eliminate body odors. Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers. Anti-germ agents

Als keimhemmende Mittel sind grundsätzlich alle gegen grampositive Bakterien wirksamen Stoffe geeignet, wie z. B. 4-Hydroxybenzoesäure und ihre Salze und Ester, N-(4- Chlorphenyl)-N'-(3,4 dichlorphenyl)harnstoff, 2,4,4 '-Trichlor-2'-hydroxy-diphenylether (Triclosan), 4-Chlor-3,5-dimethyl-phenol, 2,2'-Methylen-bis(6-brom-4-chlorphenol), 3- Methyl-4-(l -methylethyl)-phenol, 2-Benzyl-4-chlorphenol, 3-(4-Chlo henoxy)- 1 ,2- propandiol, 3-Iod-2-propinylbutylcarbamat, Chlorhexidin, 3,4,4 '-Trichlorcarbanilid (TTC), antibakterielle Riechstoffe, Thymol, Thymianöl, Eugenol, Nelkenöl, Menthol, Minzöl, Farnesol, Phenoxyethanol, Glycerinmonocaprinat, Glycerinmonocaprylat, Glyce- rinmonolaurat (GML), Diglycerinmonocaprinat (DMC), Salicylsäure-N-alkylamide wie z. B. Salicylsäure-n-octylamid oder Salicylsäure-n-decylamid.In principle, all substances effective against gram-positive bacteria are suitable as germ-inhibiting agents, such as. B. 4-hydroxybenzoic acid and its salts and esters, N- (4-chlorophenyl) -N '- (3,4 dichlorophenyl) urea, 2,4,4' -Trichlor-2'-hydroxy-diphenyl ether (triclosan), 4 -Chlor-3,5-dimethyl-phenol, 2,2'-methylene-bis (6-bromo-4-chlorophenol), 3-methyl-4- (l-methylethyl) -phenol, 2-benzyl-4-chlorophenol , 3- (4-Chlo henoxy) - 1, 2-propanediol, 3-iodo-2-propynyl butyl carbamate, chlorhexidine, 3,4,4 'trichlorocarbanilide (TTC), antibacterial fragrances, thymol, thyme oil, eugenol, clove oil, menthol , Mint oil, farnesol, phenoxyethanol, glycerol monocaprinate, glycerol monocaprylate, glycerol monolaurate (GML), diglycerol monocaprinate (DMC), salicylic acid N-alkylamides such as B. salicylic acid-n-octylamide or salicylic acid-n-decylamide.

Enzyminhibitorenenzyme inhibitors

Als Enzyminhibitoren sind beispielsweise Esteraseinhibitoren geeignet. Hierbei handelt es sich vorzugsweise um Trialkylcitrate wie Trimethylcitrat, Tripropylcitrat, Triisopro- pylcitrat, Tributylcitrat und insbesondere Triethylcitrat (Hydagen® CAT). Die Stoffe inhibieren die Enzymaktivität und reduzieren dadurch die Geruchsbildung. Weitere Stoffe, die als Esteraseinhibitoren in Betracht kommen, sind Sterolsulfate oder -phosphate, wie beispielsweise Lanosterin-, Cholesterin-, Campesterin-, Stigmasterin- und Sitosterinsul- fat bzw -phosphat, Dicarbonsäuren und deren Ester, wie beispielsweise Glutarsäure, Glu- tarsäuremonoethylester, Glutarsäurediethylester, Adipinsäure, Adipinsäuremonoethyles- ter, Adipinsäurediethylester, Malonsäure und Malonsäurediethylester, Hydroxycarb- onsäuren und deren Ester wie beispielsweise Citronensäure, Äpfelsäure, Weinsäure oder Weinsäurediethylester, sowie Zinkglycinat.Esterase inhibitors, for example, are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT). The substances inhibit enzyme activity and thereby reduce odor. Other substances which can be considered as esterase inhibitors are sterolsulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterin, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, Diethyl glutarate, adipic acid, monoethyl adipate, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester and zinc glycinate.

Geruchsabsorberodor absorbers

Als Geruchsabsorber eignen sich Stoffe, die geruchsbildende Verbindungen aufnehmen und weitgehend festhalten können. Sie senken den Partialdruck der einzelnen Komponenten und verringern so auch ihre Ausbreitungsgeschwindigkeit. Wichtig ist, daß dabei Parfüms unbeeinträchtigt bleiben müssen. Geruchsabsorber haben keine Wirksamkeit gegen Bakterien. Sie enthalten beispielsweise als Hauptbestandteil ein komplexes Zinksalz der Ricinolsäure oder spezielle, weitgehend geruchsneutrale Duftstoffe, die dem Fachmann als "Fixateure" bekannt sind, wie z. B. Extrakte von Labdanum bzw. Styrax oder be- stimmte Abietinsäurederivate. Als Geruchsüberdecker fungieren Riechstoffe oder Parfümöle, die zusätzlich zu ihrer Funktion als Geruchsüberdecker den Deodorantien ihre jeweilige Duftnote verleihen. Als Parfümöle seien beispielsweise genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten, Stengeln und Blättern, Früchten, Fruchtschalen, Wurzeln, Hölzern, Kräutern und Gräsern, Nadeln und Zweigen sowie Harzen und Balsamen. Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindungen sind Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, p-tert.-Butylcyclohexylacetat, Linalylacetat, Phenylethylacetat, Linalylben- zoat, Benzylformiat, Allylcyclohexylpropionat, Styrallylpropionat und Benzylsalicylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeu- genol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aromakomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamülenöl, Nelkenöl, Melis- senöl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetiveröl, Olibanöl, Galbanumöl, Labdanumöl und Lavandinöl. Vorzugsweise werden Bergamotteöl, Di- hydromyrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzylaceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, Hedione, Sandelice, Citronenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclover- tal, Lavandinöl, Muskateller Salbeiöl, ß-Damascone, Geraniumöl Bourbon, Cyclohexyl- salicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenyles- sigsäure, Geranylacetat, Benzylacetat, Rosenoxid, Romilat, Irotyl und Floramat allein o- der in Mischungen, eingesetzt.Suitable as odor absorbers are substances which absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixers", such as, for example, the main component. B. extracts of Labdanum or Styrax or agreed abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance. Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and twigs as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether, the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones include, for example, the jonones and methylcedryl ketone, and the alcohols are anethole, citronellellone Eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil. Bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamenaldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, mandarine lily oil, orange talc oil, orange talc oil, orange glycol oil, orange glycol oil are preferred , Lavandin oil, muscatel sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilate, irotyl and floramate alone or in mixtures.

ι Antitranspirantienι Antiperspirants

Antitranspirantien (Antiperspirantien) reduzieren durch Beeinflussung der Aktivität der ekkrinen Schweißdrüsen die Schweißbildung, und wirken somit Achselnässe und Körpergeruch entgegen. Wässrige oder wasserfreie Formulierungen von Antitranspirantien enthalten typischerweise folgende Inhaltsstoffe:Antiperspirants (antiperspirants) reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor. Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:

> adstringierende Wirkstoffe, > Ölkomponenten, nichtionische Emulgatoren,> astringent active ingredients, > Oil components, nonionic emulsifiers,

> Coemulgatoren,> Co-emulsifiers,

> Konsistenzgeber,> Consistency generator,

> Hilfsstoffe wie z. B. Verdicker oder Komplexierungsmittel und/oder> Auxiliaries such as B. thickeners or complexing agents and / or

> nichtwässrige Lösungsmittel wie z. B. Ethanol, Propylenglykol und/oder Glycerin.> non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.

Als adstringierende Antitranspirant- Wirkstoffe eignen sich vor allem Salze des Aluminiums, Zirkoniums oder des Zinks. Solche geeigneten antihydrotisch wirksamen Wirkstoffe sind z.B. Aluminiumchlorid, Aluminiumchlorhydrat, Aluminiumdichlorhydrat, Alumini- umsesquichlorhydrat und deren Komplexverbindungen z. B. mit Propylenglycol-1,2. A- luminiumhydroxyallantoinat, Aluminiumchloridtartrat, Aluminium-Zirkonium-Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients. Such suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. B. with 1,2-propylene glycol. A- aluminum hydroxyallantoinate, aluminum chloride tartrate, aluminum zirconium

Trichlorohydrat, Aluminium-Zirko-nium-tetrachlorohydrat, Aluminium-Zirkonium-pen- tachlorohydrat und deren Komplexverbindungen z. B. mit Aminosäuren wie Glycin. Daneben können in Antitranspirantien übliche öllösliche und wasserlösliche Hilfsmittel in geringeren Mengen enthalten sein. Solche öllöslichen Hilfsmittel können z.B. sein:Trichlorohydrate, aluminum-zirconium-tetrachlorohydrate, aluminum-zirconium-pentachlorohydrate and their complex compounds z. B. with amino acids such as glycine. In addition, customary oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:

> entzündungshemmende, hautschützende oder wohlriechende ätherische Öle,> anti-inflammatory, skin-protecting or fragrant essential oils,

> synthetische hautschützende Wirkstoffe und/oder öllösliche Parfümöle.> synthetic skin-protecting agents and / or oil-soluble perfume oils.

Übliche wasserlösliche Zusätze sind z.B. Konservierungsmittel, wasserlösliche Duftstoffe, pH- Wert-Stellmittel, z.B. Puffergemische, wasserlösliche Verdickungsmittel, z.B. wasserlösliche natürliche oder synthetische Polymere wie z.B. Xanthan-Gum, Hydroxyethylcellulose, Polyvinylpynolidon oder hochmolekulare Polyethylenoxide.Common water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusting agents, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as Xanthan gum, hydroxyethyl cellulose, polyvinylpynolidone or high molecular weight polyethylene oxides.

Filmbildnerfilm formers

Gebräuchliche Filmbildner sind beispielsweise Chitosan, mikrokristallines Chitosan, quater- niertes Chitosan, Polyvinylpynolidon, Vinylpynolidon-Vinylacetat-Copolymerisate, Polymere der Acrylsäurereihe, quaternäre Cellulose-Derivate, Kollagen, Hyaluronsäure bzw. deren Salze und ähnliche Verbindungen. AntischuppenwirkstoffeCommon film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpynolidone, vinylpynolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds. Antidandruff agents

Als Antischuppenwirkstoffe kommen Pirocton Olamin (l-Hydroxy-4-rnethyl-6-(2,4,4- trimythylpentyl)-2-(lH)-pyridinonmonoethanolaminsalz), Baypival® (Climbazole), Ketoconazol®, (4-Acetyl-l-{-4-[2-(2.4-dichlorphenyl) r-2-(lH-imidazol-l-ylmethyl)-l,3-dioxylan-c- 4-ylmethoxyphenyl}piperazin, Ketoconazol, Elubiol, Selendisulfid, Schwefel kolloidal, Schwefelpolyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel-teer Destillate, Salicylsäure (bzw. in Kombination mit Hexachlorophen), Undexylensäure Mo- noethanolamid Sulfosuccinat Na-Salz, Lamepon® UD (Protein-Undecylensäurekondensat), Zinkpyrithion, Aluminiumpyrithion und Magnesiumpyrithion / Dipyrithion-Magnesiumsulfat in Frage.Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-trimythylpentyl) -2- (1H) -pyridinone monoethanolamine salt), Baypival® (climbazole), Ketoconazol®, (4-acetyl-1 - {- 4- [2- (2.4-dichlorophenyl) r-2- (lH-imidazol-l-ylmethyl) -l, 3-dioxylan-c- 4-ylmethoxyphenyl} piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal, Schwefelpolyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid monoethanolamide sulfosuccinate Na salt Mo, Lamepon® UD (protein undecylenic acid condensate), zinc pyrithione, magnesium pyrithione Aluminiumpyrithion and / dipyrithione magnesium sulfate.

OuellmittelOuellmittel

Als Quellmittel für wäßrige Phasen können Montmorillonite, Clay Mineralstoffe, Pemulen sowie alkylmodifizierte Carbopoltypen (Goodrich) dienen.Montmorillonites, clay minerals, pemulene and alkyl-modified carbopol types (Goodrich) can serve as swelling agents for aqueous phases.

Insekten-RepellentienInsect repellents

Als Insekten-Repellentien kommen N,N-Diethyl-m-toluamid, 1,2-Pentandiol oder Ethyl Buty- lacetylaminopropionate in FragePossible insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl butyl acetylaminopropionate

Selbstbräuner und DepigmentierungsmittelSelf-tanners and depigmenting agents

Als Selbstbräuner eignet sich Dihydroxyaceton. Als Tyrosinhinbitoren, die die Bildung von Melanin verhindern und Anwendung in Depigmentierungsmitteln finden, kommen beispielsweise Arbutin, Ferulasäure, K jisäure, Cumarinsäure und Ascorbinsäure (Vitamin C) in Frage- ,Dihydroxyacetone is suitable as a self-tanner. Examples of possible tyrosine inhibitors which prevent the formation of melanin and are used in depigmenting agents are arbutin, ferulic acid, kjic acid, coumaric acid and ascorbic acid (vitamin C).

Hydrotropehydrotropes

Zur Verbesserung des Fließverhaltens können ferner Hydrotrope, wie beispielsweise Ethanol, Isopropylalkohol, oder Polyole eingesetzt werden. Polyole, die hier in Betracht kommen, besitzen vorzugsweise 2 bis 15 Kohlenstoffatome und mindestens zwei Hydroxylgruppen. Die Polyole können noch weitere funktionelle Gruppen, insbesondere Aminogruppen, enthalten bzw. mit Stickstoff modifiziert sein. Typische Beispiele sindHydrotropes such as ethanol, isopropyl alcohol or polyols can also be used to improve the flow behavior. Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups. The Polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are

> Glycerin; Alkylenglycole, wie beispielsweise Ethylenglycol, Diethylenglycol, Propylenglycol, Buty- lenglycol, Hexylenglycol sowie Polyethylenglycole mit einem durchschnittlichen Molekulargewicht von 100 bis 1.000 Dalton; technische Oligoglyceringemische mit einem Eigenkondensationsgrad von 1,5 bis 10 wie etwa technische Diglyceringemische mit einem Diglyceringehalt von 40 bis 50 Gew.-%;> Glycerin; Alkylene glycols, such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons; technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;

> Methyolverbindungen, wie insbesondere Trimethylolethan, Trimethylolpropan, Trimethy- lolbutan, Pentaerythrit und Dipentaerythrit;> Methyl compounds such as, in particular, trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;

> Niedrigalkylglucoside, insbesondere solche mit 1 bis 8 Kohlenstoffen im Alkylrest, wie beispielsweise Methyl- und Butylglucosid;> Lower alkyl glucosides, in particular those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;

> Zuckeralkohole mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Sorbit oder Mannit, Zucker mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Glucose oder Saccharose;> Sugar alcohols with 5 to 12 carbon atoms, such as sorbitol or mannitol, sugars with 5 to 12 carbon atoms, such as glucose or sucrose;

> Aminozucker, wie beispielsweise Glucamin;> Aminosugars such as glucamine;

> Dialkoholamine, wie Diethanolamin oder 2-Amino-l,3-propandiol.> Dialcohol amines, such as diethanolamine or 2-amino-l, 3-propanediol.

Konservierungsmittelpreservative

Als Konservierungsmittel eignen sich beispielsweise Phenoxyethanol, Formaldehydlösung, Parabene, Pentandiol oder Sorbinsäure sowie die unter der Bezeichnung Surfacine® bekannten Silberkomplexe und die in Anlage 6, Teil A und B der Kosmetikverordnung aufgeführten weiteren Stoffklassen.Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.

Parfümöle und AromenPerfume oils and flavors

Als Parfümöle seien genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten (Lilie, Lavendel, Rosen, Jasmin, Neroli, Ylang- Ylang), Stengeln und Blättern (Geranium, Patchouli, Petitgrain), Früchten (Anis, Koriander, Kümmel, Wacholder), Fruchtschalen (Bergamotte, Zitrone, Orangen), Wurzeln (Macis, Ange- lica, Sellerie, Kardamon, Costus, Iris, Calmus), Hölzern (Pinien-, Sandel-, Guajak-, Zedern-, Rosenholz), Kräutern und Gräsern (Estragon, Lemongras, Salbei, Thymian), Nadeln und Zweigen (Fichte, Tanne, Kiefer, Latschen), Harzen und Balsamen (Galbanum, Elemi, Benzoe, Mynhe, Olibanum, Opoponax). Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindungen sind Produk- te vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxyethylisobutyrat, p-tert.- Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat, Phenylethylacetat, Lina- lylbenzoat, Benzylformiat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styral- lylpropionat und Benzylsalicylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone, α-Isomethylionon und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeugenol, Geraniol, Linalool, Phenylethylalkohol und Terpi- neol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aromakomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetive- röl, Olibanöl, Galbanumöl, Labolanumöl und Lavandinöl. Vorzugsweise werden Bergamotte- öl, Dihydromyrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzylaceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, He- dione, Sandelice, Citronenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Salbeiöl, ß-Damascone, Geraniumöl Bourbon, Cyclohexylsalicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenylessigsäure, Gera- nylacetat, Benzylacetat, Rosenoxid, Romilllat, Irotyl und Floramat allein oder in Mischungen, eingesetzt.Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme) ), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (Galbanum, Elemi, Benzoe, Mynhe, Olibanum, Opoponax). Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are product esters, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linylbenzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexylpropylate propylate, pentylate propylate. The ethers include, for example, benzyl ethyl ether, the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones include, for example, the jonones, α-isomethylionone and methylcedryl ketone, and the alcohols Anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpinol, the hydrocarbons mainly include terpenes and balms. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin. Bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamenaldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, mandarin oil, allyl glycolate, allyl glycolate, orangelol oil, orangol oil, orangol oil, are preferred , Lavandin oil, muscatel sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllate, irotyl and floramate alone Mixtures used.

Als Aromen kommen beispielsweise Pfefferminzöl, Krauseminzöl, Anisöl, Sternanisöl, Kümmelöl, Eukalyptusöl, Fenchelöl, Citronenöl, Wintergrünöl, Nelkenöl, Menthol und dergleichen in Frage.Suitable flavors are, for example, peppermint oil, spearmint oil, anise oil, star anise oil, caraway oil, eucalyptus oil, fennel oil, lemon oil, wintergreen oil, clove oil, menthol and the like.

Farbstoffedyes

Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden. Beispiele sind Kochenillerot A (C.I. 16255), Patentblau V (C.I.42051), Indigotin (C.I.73015), Chlorophyllin (C.I.75810), Chinolingelb (C.I.47005), Titandioxid (C.I.77891), Indanthrenblau RS (C.I. 69800) und Krapplack (C.I.58000). Als Lumineszenzfarbstoff kann auch Lummol enthalten sein. Diese Farbstoffe werden üblicherweise in Konzentrationen von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, eingesetzt.The dyes which can be used are those which are suitable and approved for cosmetic purposes. Examples are culinary red A (CI 16255), patent blue V (CI42051), indigotine (CI73015), chlorophyllin (CI75810), quinoline yellow (CI47005), titanium dioxide (CI77891), indanthrene blue RS (CI 69800) and madder varnish (CI 58000). Lummol can also be contained as luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.

Die Herstellung der Mittel kann durch übliche Kalt - oder Heißprozesse erfolgen; vorzugsweise arbeitet man nach der Phaseninversionstemperatur-Methode. BeispieleThe agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used. Examples

A: Herstellung eines ässrigen Extraktes des Pilzes Laccaria laccataA: Preparation of an aqueous extract of the mushroom Laccaria laccata

0,015 kg des Pilzes Laccaria laccata in gepulverter Form wurden zusammen mit 0,30 1 destilliertem Wasser in ein Becherglas gegeben. Die Mischung wurde für eine Stunde bei 60 °C gerührt. Dann wurde die Mischung für 15 Minuten mit Ultraschall beschallt. Die festen Bestandteile wurden durch Filtration entfernt. Die gefilterte Lösung enthielt den rohen Extrakt. Diese gefilterte Lösung wurde 15 Minuten zentrifugiert, durch ein Filter mit einer Porenweite von 0,45 μm filtriert xmd anschließend lyophilisiert.0.015 kg of the mushroom Laccaria laccata in powdered form were placed in a beaker together with 0.30 l of distilled water. The mixture was stirred at 60 ° C for one hour. Then the mixture was sonicated for 15 minutes. The solid components were removed by filtration. The filtered solution contained the crude extract. This filtered solution was centrifuged for 15 minutes, filtered through a filter with a pore size of 0.45 μm and then lyophilized.

Die Ausbeute an Extrakt betrug 37,33 %.The yield of the extract was 37.33%.

B: Ergebnisse der WirksamkeitstestsB: Results of the effectiveness tests

B-l : Regenerierende und revitalisierende EigenschaftenB-l: Regenerating and revitalizing properties

Der Zweck der folgenden Experimente war es, die regenerierende und revitalisierenden Eigenschaften eines wässrigen Extraktes des Pilzes Laccaria laccata auf menschliche Fibroblast - Kulturen in vitro zu bestimmen.The purpose of the following experiments was to determine the regenerative and revitalizing properties of an aqueous extract of the fungus Laccaria laccata on human fibroblast cultures in vitro.

1. Effekt auf das Wachstum und den Metabolismus von Kulturen menschlicher Fibroblasten in vitro, regenerierende und revitalisierende Eigenschaften1. Effect on the growth and metabolism of cultures of human fibroblasts in vitro, regenerating and revitalizing properties

a) Toxizitätstest und Wachstumstests bei menschlichen Fibroblastena) Toxicity test and growth test in human fibroblasts

Ein Standard-Zellkulturmedixim mit fötalem Kälberserum (FCS) wurde mit menschlichen Fibroblasten beimpft. Nach einer Brutzeit von einem Tag bei 37 °C unter einer Luft- Atmosphäre, die 5 % Kohlendioxid enthielt, wurde das Zellkulturmedium ausgetauscht gegen ein Standard-Medium das je eine bestimmte Menge der zu prüfenden Substanz enthielt (siehe Tabelle). Nach einer Bebrütung von drei Tagen wurde die Zahl der lebenden Zellen bestimmt. Diese Bestimmung erfolgte über die Bestimmung des Gehaltes an Zeil-Proteinen nach der Methode von Bradford (Bradford M.M A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. (1977), Band 72, Seiten 248 bis 254). Die folgende Tabelle gibt die Ergebnisse wieder, ausgedrückt in % gegen den Vergleichstest (Zellkulturmedium ohne zu prüfende Substanz). FCS als positiv wirkende Substanz dienst zum Vergleich.A standard cell culture medix with fetal calf serum (FCS) was inoculated with human fibroblasts. After a incubation period of one day at 37 ° C. in an air atmosphere which contained 5% carbon dioxide, the cell culture medium was replaced by a standard medium which each contained a certain amount of the substance to be tested (see table). After three days of incubation, the number of living cells was determined. This determination was made by determining the Zeil protein content using the Bradford method (Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1977), Volume 72, pages 248 to 254). The following table shows the results, expressed in% against the comparison test (cell culture medium without substance to be tested). FCS as a positive substance serves for comparison.

Tabelle 1Table 1

Figure imgf000030_0001
Figure imgf000030_0001

b) Wirksamkeit auf die Überlebensrate von menschlichen Fibroblastenb) Effectiveness on the survival rate of human fibroblasts

Ein Standard-Zellkultxxrmedixxm mit FCS wurde mit menschlichen Fibroblasten beimpft. Nach einer Brutzeit von drei Tagen trat ein Ruhezustand der Zellen ein. Dann wurde das Zellkulturmedium ausgetauscht gegen ein Medium das jeweils eine bestimmte Konzentration der zu prüfenden Substanz enthielt (siehe Tabelle). Nach einer Bebrütung von drei Tagen wurde die Zahl der lebensfähigen Zellen bestimmt. Diese Bestimmung erfolgte durch die Bestimmung des Gehaltes an zellulärer DNA (durch Fluoreszenzprüfung), an ATP, an Proteinen und an GSH bezogen auf die Proteinmenge.A standard cell culture with FCS was inoculated with human fibroblasts. After a breeding period of three days, the cells became dormant. The cell culture medium was then exchanged for a medium which in each case contained a specific concentration of the substance to be tested (see table). After three days of incubation, the number of viable cells was determined. This determination was made by determining the content of cellular DNA (by fluorescence test), of ATP, of proteins and of GSH based on the amount of protein.

ATP ist eine energiereiche Verbindung und wird im wesentlichen durch Mitochondrien hergestellt. Die Zellen benötigen ATP für die Aktivität vieler Enzyme, die den Zellaufbau kontrollieren, für die Ionenkanäle, für die Nährstoffaufhahme, und für viele andere biologische Prozesse (Vasseur P., Aerts C. Appreciation de la cytotoxicite par la mesure de l'ATP. Jounal francais Hydrologie (1982) Band 9, Seiten 149 bis 156). Der Gehalt an zellulärem ATP (Ade- nosinttriphosphat) wurde durch eine enzymatische Methode bestimmt. Der Gehalt an zellulärem Protein wurde nach der Methode nach Bradford bestimmt (Bradford M.M, A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. (1977) Band 72, Seiten 248 bis 254).ATP is an energy-rich compound and is essentially produced by mitochondria. The cells need ATP for the activity of many enzymes that control cell structure, for the ion channels, for nutrient absorption, and for many other biological processes (Vasseur P., Aerts C. Appreciation de la cytotoxicite par la mesure de l'ATP. Jounal francais hydrologie (1982) volume 9, pages 149 to 156). The cellular ATP (adenosine triphosphate) content was determined by an enzymatic method. The cellular protein content was determined using the Bradford method (Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1977) Volume 72, pages 248 to 254).

GSH (Glutathion) ist ein Peptid, welches von den Zellen hergestellt wird, um sich zu schützen gegen oxidativen Stress oder bestimmte Umweltgifte wie z.B. Quecksilber oder Blei. Die drei Aminosäuren, die in der reduzierten Form von GSH enthalten sind, werden durch spezifische zytoplasmatische Enzyme verbunden, welche ATP benötigen. Eine Erhöhung der Konzentration an GSH erhöht die Aktivität von Glutathion-S-transferase, einem entgiftend wirkenden Enzym. Der Gehalt an GSH wurde nach der Methode nach Hissin bestimmt (Hissin P. J., Hilf R. A fluoromexric method for determination of oxydised and reduced Glutathione in tissus. Analytical Biochemistry (1977) Band 74, Seiten 214 bis 226).GSH (glutathione) is a peptide that is produced by the cells to protect themselves against oxidative stress or certain environmental toxins such as mercury or lead. The three Amino acids contained in the reduced form of GSH are linked by specific cytoplasmic enzymes that require ATP. Increasing the concentration of GSH increases the activity of glutathione-S-transferase, a detoxifying enzyme. The GSH content was determined by the Hissin method (Hissin PJ, Hilf R. A fluoromexric method for determination of oxidized and reduced Glutathione in tissus. Analytical Biochemistry (1977) Volume 74, pages 214 to 226).

Die Ergebnisse, ausgedrückt in % im Vergleich zum Kontrollversuch (Zellkulturmedium ohne Extrakt) sind in der folgenden Tabelle zusa mengefasst. The results, expressed in% compared to the control experiment (cell culture medium without extract) are summarized in the following table.

Tabelle 2:Table 2:

Gehalt an DNA, ATP, zellulären Proteinen und GSH/zelluläre Proteine in % im Vergleich zum Kontrollversuch (Durchschnittswert aus zwei Assays mit je drei Messungen)Content of DNA, ATP, cellular proteins and GSH / cellular proteins in% compared to the control test (average value from two assays with three measurements each)

Figure imgf000032_0001
Figure imgf000032_0001

c) Bewertung der Versuche a und bc) Evaluation of tests a and b

Bis zur Konzentration von 0,1 % zeigt der wässrige Extrakt keinerlei toxische Effekte auf das Wachstum der menschlichen Fibroblast-Kulturen in vitro. Der wässrige Extrakt stimulierte das Wachstum der Fibroblasten und ihren Energiestoffwechsel und ihren antioxidativen Stoffwechsel. Diese Ergebnisse zeigen, dass der wässrige Extrakt ein gutes Potential besitzt, um die Erneuerung von Hautzellen zu stimulieren und um das Potential der Zellen zur Bekämpfung oxidativen Stresses und die Abwehr von Umweltgiften (z. B. Schwermetalle wie Quecksilber oder Blei) zu steigern. Aus diesem Grunde ist der wässrige Extrakt ein guter Kandidat als aktiver Inhaltsstoff für kosmetische Anwendungen, um die Hautalterung zu bekämpfen und um die Haut gegen Umwelt-Stress zu schützen.Up to a concentration of 0.1%, the aqueous extract shows no toxic effects on the growth of human fibroblast cultures in vitro. The aqueous extract stimulated the growth of the fibroblasts and their energy metabolism and their antioxidative metabolism. These results show that the aqueous extract has good potential to stimulate the renewal of skin cells and to increase the potential of the cells to combat oxidative stress and to ward off environmental toxins (e.g. heavy metals such as mercury or lead). For this reason, the aqueous extract is a good candidate as an active ingredient for cosmetic applications to combat skin aging and to protect the skin against environmental stress.

II . schlankmachende WirkungII. slimming effect

a) Test an menschlichen Adipocyten ex vivo: Rate der Lipolysea) Ex vivo test on human adipocytes: rate of lipolysis

II

Hintergrund:Background:

Die Lipolyse ist die Entfernung von Triglyceriden die in Adipocyten gespeichert sind durch das Enzym Triglyceridlipase. Die Triglyceridlipase zerteilt die Triglyceride in freie Fettsäuren und Glycerin. Diese Stoffwechselprodukte werden durch den Blutkreislauf abgeführt. Die freien Fettsäuren können dann durch Muskelzellen in Energie umgesetzt werden. Versuchsprotokoll: Adipocyten wurden isoliert durch den enzymatischen Aufschluss von menschlichem subcutamen Gewebe nach der Methode von Rodbell., [Rodbell M.; Metabolism of isolated fat cells; J. Biol. Chem., 239, 2, 375-380 (1964)]. Die Extrakte oder Referenzsubstanzen wurden in einem definiertem Medium aufgelöst, welches danach mit Adipocyten über 90 Minuten bei 37 °C in Kontakt gebracht wurde. Der Gehalt an freigesetztem Glycerin (d. h. die Aktivität der Lipolyse) wurde spektoskropisch bestimmt in dem überstehenden Medium nach der Methode von Carpene C. et al. (Carpene C. et al. ; Discrimination des adrenergiques ä potentialite 2 par l'etude de la lipolyse sur des adipocytes de hamster ; J. Pharmacol. (Paris), 12, 2, 219-224 (1981)). Jeder Extrakt wurde im Vergleich zu den Referenzsubstanzen (Theophyllin und Isoprenalin) getestet. Dieser Test erfolgte an zwei bis sechs verschiedenen Proben menschlicher Adipocyten. Die Ergebnisse wurden als durchschnittlicher Wert des freigesetzten Glycerins als prozentuale Verbesserung im Vergleich zur Kontrollprüfung dargestellt (die Kontrollprüfung entspricht 0 %).Lipolysis is the removal of triglycerides stored in adipocytes by the enzyme triglyceride lipase. The triglyceride lipase breaks down the triglycerides into free fatty acids and glycerin. These metabolic products are removed through the bloodstream. The free fatty acids can then be converted into energy by muscle cells. Test protocol: Adipocytes were isolated by the enzymatic digestion of human subcutaneous tissue by the method of Rodbell., [Rodbell M .; Metabolism of isolated fat cells; J. Biol. Chem., 239, 2, 375-380 (1964)]. The extracts or reference substances were dissolved in a defined medium, which was then brought into contact with adipocytes at 37 ° C. for 90 minutes. The content of released glycerol (ie the activity of lipolysis) was determined spectoscropically in the supernatant medium according to the method of Carpene C. et al. (Carpene C. et al.; Discrimination of the adrenergiques a potentialite 2 par l'etude de la lipolyse sur des adipocytes de hamster; J. Pharmacol. (Paris), 12, 2, 219-224 (1981)). Each extract was tested against the reference substances (theophylline and isoprenaline). This test was carried out on two to six different samples of human adipocytes. The results were presented as the average value of the released glycerol as a percentage improvement compared to the control test (the control test corresponds to 0%).

Tabelle 3:Table 3:

Figure imgf000033_0001
Figure imgf000033_0001

Bei einer Konzentration von 0,1 % erfolgte eine moderate Aktivierung der Freisetzung von Glycerin durch den wässrigen Extrakt. Also hat der wässrige Extrakt ein Potential zur Stimulierung der Lipolyse und damit für einen schlankmachenden Effekt gezeigt. At a concentration of 0.1%, the release of glycerin was moderately activated by the aqueous extract. So the aqueous extract has shown a potential for stimulating lipolysis and thus for a slimming effect.

Claims

PATENTANSPRÜCHE 1. Verwendung eines Extraktes aus Myconhiza-Pilzen zur Herstellung von kosmetischen Mitteln, wobei die Myconhiza-Pilze ausgewählt werden aus der Gruppe, die gebildet wird von Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora ter- restris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporxxm, Hebeloma crusuliniforme und Glomus mosseae.1. Use of an extract from Myconhiza mushrooms for the production of cosmetic products, the Myconhiza mushrooms being selected from the group formed by Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora terresis, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporxxm, Hebeloma crusuliniforme and Glomus mosseae. 2. Die Verwendung nach Anspruch 1 zur Herstellung von kosmetischen Mitteln für empfindliche Haut oder zur Herstellung von kosmetischen Mitteln mit Anti-Aging Aktivitäten oder zur Herstellung von kosmetischen Mitteln mit anti-Protease Aktivität, insbesondere mit anti-Collagenase und/oder anti-Elastase Aktivtät oder zur Herstellung von kosmetischen Mitteln mit revitalisierenden, regenerierenden, feuchthaltenden und/oder reaktivierenden Eigenschaften für Haut und/oder Haar oder zur Herstellung von kosmetischen Mitteln mit zellschützenden oder immunabwehrstärkenden Eigenschaften, oder zur Herstellung von kosmetischen Mitteln mit lipolytischer Aktivität, insbesondere gegen Cellulitis oder zur Herstellung von kosmetischen Mitteln zur verbesserten Wundheilung2. The use according to claim 1 for the production of cosmetic products for sensitive skin or for the production of cosmetic products with anti-aging activities or for the production of cosmetic products with anti-protease activity, in particular with anti-collagenase and / or anti-elastase activity or for the production of cosmetic products with revitalizing, regenerating, moisturizing and / or reactivating properties for skin and / or hair or for the production of cosmetic products with cell-protecting or immune-strengthening properties, or for the production of cosmetic products with lipolytic activity, in particular against cellulite or for Manufacture of cosmetic products for improved wound healing 3. Die Verwendung nach Anspruch 1, dadurch gekennzeichnet, dass ein Extrakt aus Myconhiza-Pilzen als Wirkstoff in kosmetischen Mitteln zur Stimulierung der Synthese von dermalen Makromolekülen ausgewählt aus der Gruppe, die gebildet wird aus Collagen, Elastin, Fibronectin, Proteoglycanen und deren Salzen, eingesetzt wird.3. The use according to claim 1, characterized in that an extract from Myconhiza mushrooms as an active ingredient in cosmetic products for stimulating the synthesis of dermal macromolecules selected from the group consisting of collagen, elastin, fibronectin, proteoglycans and their salts, is used. 4. Die Verwendung nach Anspruch 1 zur Herstellung von kosmetischen Mitteln mit anti- alpha-5-Reductase Aktivität, insbesondere anti-Akne und anti-Sebonhea Aktivität für Haut und/oder Haar.4. The use according to claim 1 for the production of cosmetic agents with anti-alpha-5-reductase activity, in particular anti-acne and anti-Sebonhea activity for skin and / or hair. 5. Die Verwendung nach Anspruch 1 zur Herstellung von kosmetischen Mitteln gegen Alo- pecia.5. The use according to claim 1 for the production of cosmetic agents against alopecia. 6. Die Verwendung nach einem der Ansprüche 1 bis 11, dadurch gekennzeichnet, dass der Myconhiza - Extrakt aus Pilzen der Gattung Laccaria und/oder Glomus gewonnen wird.6. The use according to any one of claims 1 to 11, characterized in that the Myconhiza extract is obtained from mushrooms of the genus Laccaria and / or Glomus. 7. Ein Verfahren zur Herstellung eines Extrakts aus Myconhiza-Pilzen, wobei die Myconhiza-Pilze ausgewählt werden aus der Gruppe, die gebildet wird von Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora tenestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporxxm, Hebeloma crusuliniforme und Glomus mosseae, dadurch gekennzeichnet, dass mit einem Extraktionsmittel ausgewählt aus der Gruppe, die gebildet wird von Wasser, niedrigmoleku- laren Alkoholen, Estern, Ketonen, Kohlenwasserstoffen und halogenierten Kohlenwasserstoffen, extrahiert wird xind gegebenenfalls nachfolgend getrocknet wird.7. A process for producing an extract from Myconhiza mushrooms, the Myconhiza mushrooms being selected from the group formed by Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora tenestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporxxm, Hebeloma crusuliniforme and Glomus mosseae, characterized in that with an extracting agent selected from the group consisting of water, low molecular weight laren alcohols, esters, ketones, hydrocarbons and halogenated hydrocarbons, is extracted and optionally subsequently dried. 8. Eine kosmetische Zubereitung, dadurch gekennzeichnet, dass sie 0,001 bis 30 Gew. % eines Extraktes, der aus Myccorhiza-Pilzen gewonnen wurde - bezogen auf die Endzubereitung - enthält, wobei die Myconhiza-Pilze ausgewählt werden aus der Gruppe, die gebildet wird von Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora tenestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporum, Hebeloma crusuliniforme und Glomus mosseae.8. A cosmetic preparation, characterized in that it contains 0.001 to 30% by weight of an extract, which was obtained from Myccorhiza mushrooms, based on the final preparation, the Myconhiza mushrooms being selected from the group formed by Pisolithus tinctorius, Rhizopogon luteolus, Rhizopogon rubescens, Thelephora tenestris, Lactarius rufus, Laccaria laccata, Laccaria bicolor, Tricholoma albobruneum, Hebeloma cylindrosporum, Hebeloma crusuliniforme and Glomus mosseae. 9. Die kosmetische Zubereitung gemäß Anspruch 14, dadurch gekennzeichnet, dass der Extrakt aus Pilzen der Gattung Laccaria xxnd/oder Glomus gewonnen wird.9. The cosmetic preparation according to claim 14, characterized in that the extract is obtained from mushrooms of the genus Laccaria xxnd / or Glomus. 10. Die kosmetische Zubereitung gemäß einem der Ansprüche 14 oder 15, dadurch gekennzeichnet, dass der Extrakt aus Myccorhiza-Pilzen in verkapselter Form oder an einen Träger absorbiert vorliegt. 10. The cosmetic preparation according to one of claims 14 or 15, characterized in that the extract from Myccorhiza mushrooms is present in encapsulated form or absorbed on a carrier.
PCT/EP2004/000940 2003-02-12 2004-02-03 Use of an extract from mycorrhiza fungi Ceased WO2004071480A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0301655A FR2850868A1 (en) 2003-02-12 2003-02-12 Using extracts of Mycorrhiza in cosmetic and dermatopharmaceutical compositions, useful e.g. for treatment of sensitive skin, to prevent ageing and to improve wound healing
FR0301655 2003-02-12

Publications (1)

Publication Number Publication Date
WO2004071480A1 true WO2004071480A1 (en) 2004-08-26

Family

ID=32731970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/000940 Ceased WO2004071480A1 (en) 2003-02-12 2004-02-03 Use of an extract from mycorrhiza fungi

Country Status (2)

Country Link
FR (1) FR2850868A1 (en)
WO (1) WO2004071480A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961692A1 (en) * 2010-06-25 2011-12-30 Sothys Auriac COSMETIC USE OF EDIBLE FUNGUS EXTRACT PEDUNCLE, COSMETIC COMPOSITION COMPRISING THEM AND COSMETIC PROCESS IMPLEMENTING THEM
WO2012035209A1 (en) * 2010-09-16 2012-03-22 Metsäntutkimuslaitos Fungal extracts and uses thereof
DE202018101021U1 (en) 2017-02-24 2018-03-07 Liudmila Kalitukha Means for normalizing hair growth and head condition
CN118496390A (en) * 2024-05-08 2024-08-16 华南理工大学 Armillariella erythrorhizon purified polysaccharide and preparation method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1594884A (en) * 1968-11-26 1970-06-08
JPS60146821A (en) * 1983-12-29 1985-08-02 Sansho Seiyaku Kk Bath agent
WO1996035768A1 (en) * 1995-05-11 1996-11-14 Novo Nordisk A/S Deoxygenation of an oil product with a laccase
JPH09227333A (en) * 1996-02-28 1997-09-02 Narisu Keshohin:Kk Cosmetics
JPH09227390A (en) * 1996-02-19 1997-09-02 Pola Chem Ind Inc Composition for improving skin condition
WO2002022095A1 (en) * 2000-09-15 2002-03-21 L'oreal Oxidation dyeing composition for keratinous fibres comprising a 5-halogeno-ortho-amino-phenol derivative in position-4
JP2002322044A (en) * 2001-04-26 2002-11-08 Rohto Pharmaceut Co Ltd Bleaching agent and composition for bleaching
DE10127610A1 (en) * 2001-06-07 2003-01-30 Knoell Hans Forschung Ev New use of lanostane derivatives for treating or preventing inflammatory conditions, and as inhibitors of 3-alpha-hydroxysteroid dehydrogenase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0427333A (en) * 1990-05-24 1992-01-30 Kazuko Asai Sterilization apparatus
FR2703927B1 (en) * 1993-04-13 1995-07-13 Coletica Use of a transacylation reaction between an esterified polysaccharide and a polyamine to form in an aqueous medium a membrane at least on the surface of gelled particles.

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1594884A (en) * 1968-11-26 1970-06-08
JPS60146821A (en) * 1983-12-29 1985-08-02 Sansho Seiyaku Kk Bath agent
WO1996035768A1 (en) * 1995-05-11 1996-11-14 Novo Nordisk A/S Deoxygenation of an oil product with a laccase
JPH09227390A (en) * 1996-02-19 1997-09-02 Pola Chem Ind Inc Composition for improving skin condition
JPH09227333A (en) * 1996-02-28 1997-09-02 Narisu Keshohin:Kk Cosmetics
WO2002022095A1 (en) * 2000-09-15 2002-03-21 L'oreal Oxidation dyeing composition for keratinous fibres comprising a 5-halogeno-ortho-amino-phenol derivative in position-4
JP2002322044A (en) * 2001-04-26 2002-11-08 Rohto Pharmaceut Co Ltd Bleaching agent and composition for bleaching
DE10127610A1 (en) * 2001-06-07 2003-01-30 Knoell Hans Forschung Ev New use of lanostane derivatives for treating or preventing inflammatory conditions, and as inhibitors of 3-alpha-hydroxysteroid dehydrogenase

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198537, Derwent World Patents Index; Class D16, AN 1985-226617, XP002257315 *
DATABASE WPI Section Ch Week 199828, Derwent World Patents Index; Class B04, AN 1998-315291, XP002257313 *
DATABASE WPI Section Ch Week 200339, Derwent World Patents Index; Class B04, AN 2003-407249, XP002257314 *
L. KARDONO ET AL.: "Chemical constituents of scleroderma aurantium I: a new triterpene, 3,25-dihydroxy-22-acetoxyl-lanosta-8, 23-diene", EURASIAN JOURNAL OF FOREST RESEARCH, vol. 5, 2002, pages 33 - 37, XP001189212 *
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 01 30 January 1998 (1998-01-30) *
Y. TSANTRIZOS ET AL.: "Antifungal antibiotics from Pisolithus Tinctorius", PHYTOCHEMISTRY, vol. 30, no. 4, 1991, GB, pages 1113 - 1118, XP001190849 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961692A1 (en) * 2010-06-25 2011-12-30 Sothys Auriac COSMETIC USE OF EDIBLE FUNGUS EXTRACT PEDUNCLE, COSMETIC COMPOSITION COMPRISING THEM AND COSMETIC PROCESS IMPLEMENTING THEM
WO2012035209A1 (en) * 2010-09-16 2012-03-22 Metsäntutkimuslaitos Fungal extracts and uses thereof
EP2616088A4 (en) * 2010-09-16 2013-07-31 Metsaentutkimuslaitos Fungal extracts and uses thereof
DE202018101021U1 (en) 2017-02-24 2018-03-07 Liudmila Kalitukha Means for normalizing hair growth and head condition
CN118496390A (en) * 2024-05-08 2024-08-16 华南理工大学 Armillariella erythrorhizon purified polysaccharide and preparation method and application thereof

Also Published As

Publication number Publication date
FR2850868A1 (en) 2004-08-13

Similar Documents

Publication Publication Date Title
EP1392237B1 (en) Cosmetic preparations containing an extract of germinating rye
EP1296701B1 (en) Use of grifola frondosa fungus extracts
EP1339421B1 (en) Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa
EP1461059A1 (en) Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
EP1239826A2 (en) Cosmetic and/or pharmaceutical preparations
EP1372685B1 (en) Use of extracts of the plant litchi chinensis sonn.
WO2002045728A1 (en) Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa
EP1487400A2 (en) Cosmetic agents
EP1281392A1 (en) Cosmetic or/and pharmaceutical compositions containing plant extracts
WO2003015738A1 (en) Active ingredient mixtures
EP1385473A1 (en) Use of oligomeric proanthrocyanidins
EP1313497A1 (en) Use of extracts of the cassia alata plant
EP1343468A1 (en) Method for protecting the skin from aging
EP1441747A2 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
EP1585495A1 (en) Use of oligoglucosamines in cosmetic or dermatological preparations
EP1314420A1 (en) Anti-ageing composition
EP1635910A1 (en) Cosmetic and/or dermatological preparations containing an extract from the seeds of plants of the genus adenanthera
EP1499282A2 (en) Anti-aging compositions comprising extracts from the species arctium
WO2004071480A1 (en) Use of an extract from mycorrhiza fungi
WO2003053374A1 (en) Use of an extract of the baptisia tinctoria plant in a cosmetic composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase